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ABSTRACT 
Fluoroquinolones are antibiotics which act by penetrating into bacterial cells and 
inhibiting enzymes related to DNA replication. The misuse of fluoroquinolones has 
resulted in increased resistance to these antibiotics, which constitutes a serious public 
health issue. One mechanism of bacterial resistance to fluoroquinolones is a decrease 
in the intracellular concentration of the antibiotic due to mutations in the channel 
proteins OmpC and OmpF. Therefore, the study of membrane-antibiotic interactions 
can be an important tool for improving the understanding of bacterial resistance to 
fluoroquinolones and an aid in the design of modified fluoroquinolones with improved 
abilities to cross the bacterial membrane.   
Our work studies the interaction between sparfloxacin, a third-generation non-
fluorescent fluoroquinolone, and E.coli total lipid extract, a model for Gram-negative 
bacteria membranes. The partition coefficient of sparfloxacin in E.coli liposomes, was 
determined using multiple techniques (19F NMR spectroscopy, UV-visible absorption 
spectroscopy, and fluorescence spectroscopy). Similar partition coefficient values were 
obtained from the three different techniques, confirming that this is a useful approach to 
the determination of partition coefficients for non-fluorescent drugs. 
As channel proteins are a specific pathway for the uptake of fluoroquinolones through 
the bacterial membrane, we also studied the interaction between sparfloxacin and 
E.coli total/OmpF proteoliposomes by two different techniques: fluorescence quenching 
of OmpF-tryptophans and Surface Plasmon Resonance (SPR). 
Multiple studies suggest that fluoroquinolone complexation with copper(II), result in 
compounds with enhanced antibacterial activity and that can use a different 
translocation route. Therefore, we amplified our study to the complex of sparfloxacin 
with phenanthroline and copper(II). Partition coefficient of sparfloxacin copper-complex 
was determined using fluorescence spectroscopy in the presence of fluorescence 
probes and association constant was determined using the same approaches that were 
used for sparfloxacin free-drug. 
Our results suggest that sparfloxacin is a peculiar fluoroquinolone, concerning to its 
transport across the bacterial membrane. Apparently, besides the OmpF dependent 
transport, sparfloxacin can use an alternative pathway to enter bacterial cell, perhaps a 
different channel protein. Moreover, our results suggest that copper-sparfloxacin 
complexes can use a different route to enter bacterial cell, possibly promoted by the 
high lipid/antibiotic superficial interaction but they cannot pass through the membrane 
lipid bilayer. 
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RESUMO 
Fluoroquinolonas são antibióticos que actuam pela inibição de enzimas relacionadas 
com a replicação do ADN. O uso indevido de fluoroquinolonas resultou no aumento da 
resistência a estes antibióticos, o que constitui um grave problema de saúde pública. 
Uma vez que o alvo de acção das fluoroquinolonas é intra-celular, um importante 
mecanismo de resistência bacteriana às fluoroquinolonas é uma redução da 
concentração intracelular do antibiótico devido à mutação das proteínas 
transportadoras OmpC e OmpF. Desta forma, o estudo de interações membrana-
antibiótico pode ser uma ferramenta importante para aumentar o conhecimento acerca 
da resistência bacteriana às fluoroquinolonas e uma ajuda no desenvolvimento de 
novas fluoroquinolonas com maior capacidade de atravessar a membrana bacteriana.  
No presente trabalho estudou-se a interação entre a sparfloxacina, uma 
fluoroquinolona não fluorescente de terceira geracção, e extrato lipidico total de E.coli, 
um modelo de membranas de bactérianas Gram-negativas. O coeficiente de partição 
da sparfloxacina em lipossomas de E.coli, foi determinado utilizando várias técnicas 
(espectroscopia de 19F RMN, espectroscopia de absorção UV-visível e espectroscopia 
de fluorescência). Valores de coeficiente de partição semelhantes foram obtidos a 
partir das três técnicas diferentes, confirmando que esta é uma abordagem útil para a 
determinação dos coeficientes de partição de drogas não fluorescentes.  
A permeação das fluoroquinolonas através da membrana bacteriana está ligada à 
presença de proteínas transportadoras. Deste modo, a interação entre a sparfloxacina 
e proteolipossomas de E. coli / OmpF, foi também estudada, utilizando duas técnicas 
diferentes: extinção de fluorescência da OmpF e ressonância de plasma de superfície 
(SPR).  
Vários estudos sugerem que a complexação de fluoroquinolonas com cobre (II), 
resulta em compostos com actividade antibacteriana melhorada e que podem utilizar 
uma rota de permeação diferente. Por esse motivo, o complexo de sparfloxacina com 
fenantrolina e cobre (II), foi também estudado. O coeficiente de partição do complexo 
de cobre(II) de sparfloxacina foi determinada usando espectroscopia de fluorescência 
na presença de sondas de fluorescência e a constante de associação foi determinada 
usando os mesmos métodos que foram utilizados para a sparfloxacina na sua forma 
livre.  
Os nossos resultados sugerem que a sparfloxacina é uma fluoroquinolona peculiar, 
relativamente ao seu transporte através da membrana bacteriana. Aparentemente, 
além do transporte dependente de OmpF, a sparfloxacina pode usar uma via 
alternativa para entrar na célula bacteriana, possivelmente, uma proteína canal 
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diferente. Além disso, os nossos resultados sugerem que o complexo de cobre de 
sparfloxacina pode usar uma via diferente para entrar célula bacteriana, possivelmente 
promovida pela elevada interacção superficial entre o antibiótico e as cabeças polares 
dos lípidos membranares, mas não são capazes de atravessar a bicamada lipídica. 
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1. Quinolones 
Quinolones are antibacterial drugs that act by inhibiting bacterial DNA topoisomerase 
enzymes [1]. The first quinolone, nalidixic acid (fig.1), introduced in the market in 1962, 
was derived from the commercial preparation of cloroquine and had activity against 
Gram-negative (Gram -) bacteria [2, 3]. Due to its low oral absorption, this compound 
was only used for urinary tract infections (UTIs). Moreover, it was found that a number 
of organisms could rapidly develop resistance to it [4]. Therefore, it was necessary to 
develop quinolones with a broader spectrum of action, better pharmacokinetic 
properties and improved capacity to counteract bacterial resistance. This necessity 
culminated in the development of four generation of quinolones, effective against both 
Gram - , Gram-positive (Gram +) bacteria, anaerobic bacteria and also mycobacterium 
[1, 5].  
 
Fig. 1 Structure of the Nalidixic acid. 
 
 
1.1 The Evolution of Quinolones 
The development of new quinolones derived from the nalidixic acid was based on 
ligand modifications in a common nucleus structure. This structure is a 4-oxo-1,8-
naphthyridin-3-carboxylic acid ring (Fig.2). Due to its complex nomenclature and since 
they all have a exo-cyclic oxygen in position 4, these drugs are commonly known as 4-
quinolones [6].  
The main difference between the nalidixic acid and the typical quinolone ring structure 
is that nalidixic acid nucleus has two nitrogens in positions 1 and 8 and a quinolone 
ring has just one nitrogen in position 1 (Fig.1 and 2).   
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Fig. 2  Basic structure of the 4-quinolones (4-oxo-1,8-naphthyridin-3-carboxylic acid). 
 
 
1.1.1 Structure-Activity Relationships 
A characteristic of all quinolones that remains from the nalidixic acid is the presence of 
the exo-cyclic oxygen at position 4 and the carboxylic acid side chain at position 3.  
These ligands with these substituents, in these specific positions, have been found to 
be essential to the anti-bacterial activity of quinolones, since they are believed to be the 
portion of the molecule that binds to the DNA enzymes in the bacterial cell  [7]. 
Moreover, modification of the hydrogen to a larger group in position 2 of the ring may 
interfere with the stereochemistry of the binding site (positions 3 and 4), inhibiting its 
activity. Thus, modifications on these positions were rarely attempted and resulted in 
molecules with decreased antibacterial activity [8]. However, many substitutions have 
been made in other position of the ring, resulting in major effects on the drug activity. 
At position 1, the addition of large groups linked to the nitrogen present in the ring 
caused improvements in activity against both Gram – and Gram + bacteria [4]. The 
substitution of the hydrogen, in position 5, for small groups, as -CH3 or -NH2, caused 
improvements in the activity against Gram + bacteria. However, substitution for bulky 
groups resulted in decreased antibacterial activity, probably due to stereochemical 
interference with the binding site (positions 3 and 4) [9]. At position 7, the insertion of a 
heterocyclic nitrogen-containing ring was proved to improve the antibacterial activity of 
the drug. Moreover this insertion at position 7 also conferred, generally, activity against 
Gram + bacteria [9]. The insertion of a methoxy or halogen group at position 8 
improved anti-anaerobic bacteria activity [9].  
Finally, the addition of a fluoride group at position 6 resulted in improved anti-bacterial 
activity since it enhanced DNA gyrase binding and cell penetration giving rise to the 
emergence of the fluoroquinolones.  
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1.1.2 Generations of Quinolones 
The alterations on the basic structure of the nalidixic acid gave rise to the emergence 
of new quinolones, with improved antimicrobial potency and a broader spectrum of 
action. These modifications resulted in four different generations of quinolones, 
classified according to its antimicrobial activity. The main constituents and 
characteristics of each quinolone generation are represented in table 1. 
 
Table 1 Comparison between quinolone generations: main constituents, antimicrobial activity and therapeutic 
indications [2].  
 Constituents Activity Indication 
First 
generation 
Nalidixic acid Gram –  
(moderate activity) 
Uncomplicated urinary 
tract infections Cinoxacin 
Second 
generation 
Class I 
Lomefloxacin, 
Norfloxacin, 
Enofloxacin  
Gram – 
Gram + 
(moderate activity) 
Uncomplicated urinary 
tract infections 
Class II 
 
Ofloxacin 
Ciprofloxacin 
 
Gram – 
Gram + 
Complicated urinary tract 
infections  
Gastroenteritis 
Prostatitis  
Nosocomial infections 
Sexually transmitted 
diseases 
Third  
generation 
Levofloxacin 
Sparfloxacin 
Gatifloxacin 
Moxifloxacin 
Gram – 
Gram + 
Similar to class II second 
generation 
Community-acquired 
pneumonia  
Fourth 
generation 
Trovafloxacin 
Gram – 
Gram + 
(improved activity) 
Anaerobic 
Intra-abdominal 
infections 
 
 
1.2 Sparfloxacin 
The quinolone used in this study was sparfloxacin (spx) (fig.13). This is a third-
generation quinolone that belongs to the group of the fluoroquinolones. The term 
fluoroquinolone is a result of the addition of a fluoride atom in the position 6 of the 4-
quinolones basic ring. Moreover, this fluoride addition results in a huge improvement 
on the drug anti-bacterial activity.   
The main characteristic of spx is the presence of an extra fluoride in position 8. The 
addition of this fluoride is thought to increase drug’s absorption (bioavailability),plasma 
half-life and to increase its activity against Gram + bacteria [10]. Due to its broad 
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spectrum of action and good pharmacokinetic characteristics, spx is potentially used 
drug in the combat of respiratory tract infections [10-12].  
However, the presence of the fluoride in the position 8 of the ring has been related with 
phototoxicity that is associated with some adverse secondary effects, which limit the 
clinical use of spx [4].  
Even though its secondary effects, spx has been widely used in the treatment of 
respiratory diseases due to its favourable pharmacokinetic characteristics that allow 
once-daily dosing, improving adherence to therapy and cost-effectiveness [10]. 
Thereby, the study of spx is fundamental in order to find new insights to combat 
bacterial resistance to this drug.  
 
 
1.2.1 Physicochemical Properties of Spx  
As the other fluoroquinolones, spx is an amphoteric molecule that can behave as an 
acid or a base. Therefore, depending on the pH of the media, spx can exist either in 
anionic, cationic or zwitterionic/neutral form. The pharmacological behaviour of a drug 
is dependent on its physicochemical characteristics [13]. Thus, acid-base properties 
and hydrophobicity are characteristics that determine the potential of a drug to enter in 
the bacterial cell.  
At physiological pH (pH=7.4), spx is mainly in the zwitterionic form (pKa1= 6.13, pKa2= 
7.43), but its ratio between neutral and zwitterionic form is substantially smaller than 
the one of other fluoroquinolones ([spx]±/[spx]=20.0) characteristic that is favourable to 
its antibacterial activity [14]. However, spx is a hydrophilic molecule (logP= [-0.31, -
0.41]) so it is expected that it doesn’t pass through the lipid membrane of bacteria 
without the help of a transport protein [15].  
 
 
Fig. 3 Structure of sparfloxacin [16]. 
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1.3 Mechanism of Action of Quinolones 
Quinolones act by inhibiting two essential bacterial enzymes: DNA gyrase 
(topoisomerase II) and topoisomerase IV [1, 5, 17]. These enzymes are both essential 
to the process of replication of the bacterial DNA.  Gyrase is responsible for controlling 
DNA negative supercoiling and topoisomerase IV is responsible for decatenating DNA 
after the replication process. 
The inhibition of these enzymes by quinolones would lead to bacterial cell death since 
they are required for cell growth and division. However, it is suggested that quinolones 
can form complexes with gyrase/topoisomerase IV and DNA that not only block DNA 
replication but also kill the bacterial cells by the release of double-strand DNA breaks 
[17]. 
 
 
1.4 Bacterial Resistance to Quinolones 
The abusive use of quinolones has been resulting in the increase of bacterial 
resistance to these drugs, especially in pseudomonas and staphylococcus [18]. 
The bacterial resistance to quinolones occur by two main mechanisms: Mutation of the 
target-molecules (DNA gyrase and topoisomerase IV) and decrease of quinolone 
intracellular concentration [1, 19]. 
Since the targets of quinolones are intracellular enzymes, the permeation of these 
drugs through the bacterial membrane is essential to its bactericide activity. Therefore 
the decrease of quinolone intracellular concentration is an important mechanism of 
bacterial resistance. 
The increase of quinolone efflux through efflux bombs that transport the drug to the 
exterior of the bacterial cell is one of the main mechanisms of decreasing drug 
intracellular concentration[20, 21]. Mutations in the genes that regulate efflux bombs 
expression cause an increase in the expression of these bombs and thus bacterial 
resistance to quinolones. Moreover, these efflux bombs can also transport other 
antibiotics and consequently contribute for multidrug resistance [19, 21]. 
Studies focusing on quinolones permeation on bacteria showed that the transport 
through Gram – bacteria outer membrane is dependent of transport proteins, 
specifically OmpC and OmpF porins [22]. Thus, another major mechanism of bacterial 
resistance to quinolones is the mutation in the genes that are responsible for porins 
expression [23]. In the specific case of spx, microbiological studies showed that, 
apparently, this antibiotic is not totally dependent neither on OmpF nor OmpC to its 
FCUP 
Fluoroquinolone Transport Through Bacterial Membranes: A Multi-Technique Approach 
7 
 
7 
 
intracellular transport. However the mutation of OmpC increased spx potential 
suggesting that maybe an increase in OmpF concentration through a compensation 
bacterial mechanism will help the entrance of spx [14].  
 
 
1.5 Metal Complexes of Quinolones 
Since mutation in the porins is an important mechanism of bacterial resistance, the 
discovery of new antibacterial agents with a different route of membrane permeation 
can be essential to counteract bacterial resistance. Consequently, an important field of 
research that has been developed in the effort to combat bacterial resistance to 
quinolones is the complexation with divalent metals [14, 24, 25]. 
The oxo group at position 4 and the carbonyl group at position 3 of the quinolone ring 
are the potential targets for complexation with divalent metals. Studies of solution 
behaviour of quinolone metal complexes showed that only copper(II) [Cu(II)] complexes 
were stable in solution under biological conditions [14]. Moreover, Cu(II) 
fluoroquinolone complexes have increased activity when they form a ternary-complex 
with the drug and a nitrogen-donor heterocyclic ligand, such as 1,10-phenathroline 
(phen) [26]. 
[Cu(II)/quinolone/phen] complexes show an antibacterial potential comparable to that of 
the free drug but a different route of entry in the bacterial cell. [14, 27-29]. 
Studies on [Cu(II)/spx/phen] complexes showed either a similar or higher antibacterial 
potential when compared to the free-drug [14, 30, 31] and a higher activity when 
compared to other [Cu(II)/quinolone] complexes [30]. Moreover, unlike its free form, 
[Cu(II)/spx/phen] antibacterial activity is, apparently, unaffected by the absence of 
either one of the porins, suggesting a different mechanism of permeation into the 
bacterial cell. For all these reasons, [Cu(II)/spx/phen] (fig.4) is a potential drug to be 
used in the near future and its further study has high relevance.  
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Fig. 4 Single x-ray structure of[ Cu(II)/spx/phen] metal complex  [32]. 
 
 
 
2. Bacterial Structure 
Bacteria are microorganisms constituted by a prokaryotic cell. The internal structure of 
a prokaryotic cell is simpler than the eukaryotic cell, since there are no sub-cellular 
compartments and all components are localized in the cytoplasm. However, all 
prokaryotic cells are protected by cell wall and plasma membrane, both having a 
crucial role in bacteria survival. [33]  
The plasma membrane is composed by a lipid bilayer and constituted by numerous 
integral and periphery proteins. It is the place where some metabolic process occur 
(i.e. cellular respiration). Moreover, plasma membrane is responsible for nutrient 
transport and confers selective permeability to the bacterial cell. [33] 
The cell wall confers mechanical protection to the osmotic stress and its chemical 
composition allows the distinction between Gram – and Gram + bacteria (fig.5).  
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Fig. 5 Comparison between Gram – and Gram + bacteria cell wall and membrane. Adapted from [34] 
 
The cell wall of Gram + bacteria is essentially composed by a thick layer of 
peptidoglycan, associated with teichoic and lipoteichoic acids. On the other hand, the 
cell wall of Gram – bacteria is composed by a thinner peptidoglycan layer compressed 
between an inner and an outer cell membrane. Moreover, there are neither teichoic nor 
lipoteichoic acids associated with Gram – bacteria cell walls but there are 
lipopolysaccharides associated with the cell outer membrane. [33] 
Since Gram – bacteria are the main target for quinolones and also since they have a 
lipid outer membrane as its first barrier from the outside, the focus of our study is on 
the interaction between spx and the Gram – bacteria outer membrane. 
 
 
2.1 Gram – Bacteria Outer Membrane 
As referred before Gram – bacteria have two lipid membranes, the inner and the outer 
membrane. These membranes differ either in its composition and function. Bacterial 
inner membrane is mainly composed of phosphatidylethanolamine (PE), 
phosphatidylglycerol (PG) and cardiolipin lipids. Unlike inner membrane, bacterial outer 
membrane is highly asymmetric: its inner leaflet has the same lipid composition as the 
inner membrane but its outer leaflet is mainly composed of LPS. [35] 
LPS is composed by three different regions: the Lipid A is the most hydrophobic region, 
which is integrated in the outer leaflet of the outer membrane, then the core 
oligosaccharide links lipid A to the most external region of LPS, the O-antigen  (fig.5) 
Gram + Gram – 
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[36]. LPS is an essential constituent of Gram – bacteria because LPS molecules can 
interact with each other through divalent cations, forming a permeability barrier that 
prevents the entry of small hydrophobic molecules (i.e. antibiotics, bile salts or 
detergents) [37]. Moreover, the presence of LPS increases substantially bacterial 
virulence, since the interaction between Lipid A and macrophages results in a strong 
pro-inflammatory response, culminating in septic shock and associated organ failure 
[38].   
Bacterial outer membrane is also composed by numerous integral proteins, as OmpA 
and other porins [35]. According to its solute selectivity, porins can be classified as 
general or specific porins. General porins transport small hydrophilic molecules, 
however they can have a slightly selectivity for the charge of the molecules: OmpC and 
OmpF transport cationic solutes and PhoE transports anionic solutes. The specific 
porins, as the name suggests, transport only specific molecules, since they have a 
specific binding site inside its channel. [39] 
As described before, quinolones transport through bacterial outer-membrane is 
suggested to be dependent on general porins OmpF and OmpC [22]. Therefore, in this 
study we will focus on the interaction between spx and OmpF porin. 
 
 
2.2 The OmpF Porin 
OmpF protein is a homo-trimer, each monomer consisting in a hydrophilic channel that 
transports cationic small molecules (  600 Da).  Each OmpF channel has 12 Å of 
diameter and is constituted by 340 amino acids, organized in a β-barrel structure. Each 
barrel is composed by 16 β-sheets, linked by loops and tilted by 30 to 60° in relation to 
the channel axis. [39] 
The trimer structure is stabilized by hydrophobic and polar interactions between the 
monomers. Loop 2 play a significant role in trimer-structure stabilization since it bends 
over the neighbour subunit (fig 6 A). The channel size is mainly determined by the loop 
3, which is especially long and folds into the barrel, forming the constricted area of the 
channel (fig 6 A). The main amino-acids that forms the constricted zone of the pore are 
Glu117 and Asp113 from the Loop 3 and Lys16, Arg42, Arg82 and Arg132 from the 
opposite barrel wall (fig 6 C). It is suggested that OmpF is impermeable to hydrophobic 
molecules mainly due to the constitution of its constricted zone: the cationic and 
anionic amino acid residues, located in opposite sides of the channel orient water 
FCUP 
Fluoroquinolone Transport Through Bacterial Membranes: A Multi-Technique Approach 
11 
 
11 
 
molecules inside the channel in a highly ordered structure, making its disruption by 
hydrophobic solutes energetically unfavourable. [39, 40] 
Furthermore, the selectivity of OmpF channel to cationic molecules is also explained by 
the nature of the residues that form the constricted zone of the pore (fig. 6C). Studies 
have shown that the different selectivity of OmpF and PhoE porins is related with the 
replacement of Gly131 in OmpF (localized in the constricted zone) for a positively 
charged Lys125 in PhoE [41, 42]. 
 
Fig. 6 Structure of the OmpF porin of E.coli. Loop 2 is represented in blue and Loop 3 is represented in orange. A- View 
of the trimer from the top. B- Side view of a monomer. C- Representation of the constricted zone of the channel. [39] 
 
 
2.2.1 Spectroscopic Characteristics of OmpF 
Proteins have intrinsic fluorescence due, mainly, to its residues of tryptophan (Trp) and 
tyrosine (Tyr). This characteristic is very important since it allows the study of the 
interaction between a drug and a protein by analysing the variation in the fluorescence 
emission of the protein without and with increasing concentration of drug. [43] 
OmpF contains two tryptophan residues in each monomer, with different location: 
Trp214 is at lipid-protein interface and Trp61is at the interface between two monomers 
of the trimer (Fig.7) [44]. The low wavelength of the maximum of fluorescence emission 
of OmpF suggests that both tryptophans are in hydrophobic environments [43]. Further 
studies showed that Trp61 maximum emission wavelength is lower than the one of 
Trp214. This proofs that Trp61 is located in a more hydrophobic environment than 
Trp214. [42, 45] 
Despite the presence of tyrosine residues in OmpF, it was shown that its fluorescence 
is mainly due to its tryptophan residues. This is explained by the fact that the tyrosine 
fluorescence is extinct, may be due to energy transfer to the tryptophan. [45] 
Therefore, in the present study, spx interaction with OmpF porin was studied by 
fluorescence spectroscopy, following the change in the tryptophans fluorescence 
emission in the presence of different amounts of spx.  
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Fig. 7 The position of Trp61 and Trp214 in each OmpF monomer. [45] 
 
 
 
3. Liposomes 
Liposomes are self-assembled colloidal particles composed of amphiphilic molecules, 
commonly phospholipids and cholesterol. These colloidal structures consist in spherical 
vesicles with one or more lipid bilayers surrounded by an aqueous phase. The lipids 
are organized with its polar heads oriented for the aqueous media located either in the 
interior or exterior of the vesicle. Liposomes can be classified according to its size and 
number of bilayers: multilamellar vesicles (MLVs) are composed by two or more lipid 
bilayers and unilamellar vesicles are composed by just one bilayer and can be divided 
into large unilamellar vesicles (LUVs) or small unlilamellar vesicles (SUVs). [46, 47] 
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Fig. 8 Different types of liposomes and its structure. Adapted from [46]. 
Liposomes have numerous applications in different scientific areas. However, its main 
applications are as vectors for drug delivery and models for biological membranes. In 
this study we use liposomes as models for mimicking bacterial outer membrane of 
Gram – bacterial in order to study the interaction of spx with the membrane. 
 
 
3.1 Liposomes as a Model for Biological Membranes 
The lipids used in the preparation of liposomes can be either natural or synthetic. 
Moreover, liposomes can be formed both by single or mixed phospholipids and also by 
other lipidic molecules, as cholesterol. These characteristics make liposomes an 
excellent model to mimic biological membranes, since it is possible to form structures 
with lipid compositions very similar to the biomembranes to mimic. [46]  
The size and number of bilayers of the liposomes are important properties to take into 
account in order to find a model for a biological membrane. Unilamellar vesicles are 
better systems than MLVs, since they are formed by a single bilayer as biomembranes. 
Due to its high curvature, SUVs present some abnormalities in lipid packing that make 
them very sensitive to degradation by biomolecules. Therefore, LUVs have been 
considered the best systems to be used as biomembrane models.[48] 
One of the approaches used to produce LUVs is the extrusion of a suspension of 
MLVs, previously obtained by stirring of a dispersion of phospholipids in an aqueous 
solution. The extrusion method is based on the extrusion of a MLVs suspension 
through a polycarbonate membrane with a well-defined pore diameter (usually 100nm). 
After extrusion of the MLVs, a homogeneous suspension of LUVs, with similar size, is 
obtained.  [49, 50] 
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As described before, the lipids that form the Gram – bacteria membrane are mostly PE, 
PG and cardiolipin. The membrane of E.coli, specifically, is composed of PE (57%), 
PG(15%), Cardiolipin (10%) and other lipids (18%) [51]. Therefore, in this study we 
studied the interaction of spx with LUVs of a natural E.coli total lipid extract in order to 
correctly mimic the E.coli membrane. Moreover, due to the complexity of this natural 
system, we also used LUVs of PE:PG (75:25), as a synthetic model, in order to validate 
the results obtained with the natural lipid extract.  
 
 
3.1.1 Protein Insertion in Liposomes  
As described above one important pathway of drugs transport across the bacterial 
membrane are membrane proteins. Specifically for quinolones, its transport is, 
apparently, dependent on porins OmpF and OmpC. [22]  
A very useful approach to study the interaction of drugs with membrane proteins is the 
protein purification and insertion in liposomes (model membrane), leading to the 
formation of proteoliposomes. However, the correct reconstitution of the protein in the 
liposome is essential to preserve its activity. Therefore, the final orientation of the 
protein, the homogeneity of protein insertion and the morphology and size of the 
proteoliposomes are essential parameters in the study of drug-protein interaction. 
Since membrane proteins are generally purified using detergents, the most used 
membrane protein reconstitution procedures are detergent-mediated methods. [52]  
In this study, OmpF was reconstituted in E.coli natural lipid extract liposomes by 
addition of a detergent/protein mixture to a suspension of pre-formed liposomes.  
It is essential to this procedure that detergent is added at a concentration above the 
critical micelle concentration (CMC) of detergent-micelle formation but below CMC of 
lipid-detergent mixed micelles formation. Detergent, at this concentration, stabilizes the 
protein in a soluble form and disrupts lipid-lipid interactions, increasing the permeability 
of the lipid bilayer without breaking, however, the liposome structure. Moreover, this 
method allows the incorporation of the protein with a correct orientation. Figure 9 show 
the effect of addition of increasing amounts of detergent to liposomes.  
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Fig. 9 Lamellar to micelle transition of the lipid upon increasing of detergent concentration. [52] 
Fig. 10 shows the three different methodologies of detergent-dependent protein 
incorporation in liposomes. The methodology used in this study is depicted in figure 
10A. [52-55] 
Detergent can be removed afterwards by several methods, such as dialysis, column 
chromatography or use of detergent-adsorbing beads. Several studies demonstrated 
that the use of polystyrene beads is an efficient method to remove detergent, since it 
allows an almost complete removal of any kind of detergent [52, 56]. Therefore, in this 
study we used polystyrene detergent-adsorbing beads in order to remove detergent. 
 
 
Fig. 10 Mechanisms of detergent-mediated protein reconstitution. A shows direct incorporation of protein in detergent-
saturated liposomes ( at Rsat) ;  B shows transfer of protein from mixed micelles to detergent-saturated liposomes 
(above Rsar and below Rsol); C shows proteoliposome formation by micellar coalescence. Note that only mechanism A 
allows the correct orientation of all the inserted protein molecules. [52] 
  
 
 
 
A 
B 
C 
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4. Partition Coefficient 
The determination of the partition coefficient (Kp) of a drug with the model membrane is 
the first step to be carried out in the functional study of a drug. The Kp represents a 
quantitative evaluation of the extent of interaction of the drug with a 
microheterogeneous system.  [57] 
The partition coefficient of a drug is, by definition, the ratio between the quantity of drug 
in the lipid and in the aqueous phase: 
 
   
   
       ⁄
    
      ⁄
 
 
Where      and      are drug concentration in the lipid and aqueous phase, 
respectively.         is the molar concentration of lipid and        is the molar 
concentration of water (55.5 mol.dm-3). 
There are two main different approaches used to determine the Kp of a drug with a 
model membrane: the ones that require physical separation of free and membrane-
bound drug and the ones that did not require this physical separation. Physical 
separation is a laborious technique and can result in equilibrium perturbation. 
Therefore, in this study, we used techniques that did not demand physical separation of 
free and membrane-bound drug and allow the calculation of the Kp of the drug by 
measuring a property that quantify the combination of the free and bound molecules 
signals. [57] 
The main techniques used for Kp determination without physical separation are 
spectroscopic techniques. Thereby, in this study we calculated and compared the Kp of 
spx by different spectroscopic techniques, such as: UV-vis spectroscopy, NMR 
spectroscopy and Fluorescence spectroscopy.  
 
 
4.1 Partition Coefficient by UV-vis Spectroscopy  
The Kp determination by UV-vis spectroscopy is based on the change of an absorption 
parameter of the drug caused by its incorporation into the lipid bilayer. [58] 
 
 
1) 
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Absorbance is proportional to drug concentration at a specific wavelength:  
 
                   
 
Where    and    are drug molar extinction coefficients in the lipid and aqueous phase, 
respectively. 
Therefore, Kp can be calculated from the difference between absorption in the 
presence and absence of liposomes (   ), rewriting eq. 1) as: 
 
     
               
                  
 
 
Where         . 
The use of derivative spectrophotometry allows the elimination of the effect of 
background signals, as scattering from the lipid, and the improvement of the resolution 
of overlapped signals [59]. Since derivative absorbance is also proportional to drug 
concentration, Kp can be determined by the use of derivative spectrophotometry using 
and equation very similar to equation 3):  
 
    
               
                  
 
 
Where   
   
   
 and    
   
   
 . 
Therefore, Kp can be calculated by UV-vis spectroscopy from the non-linear fit of
         (       ), for a constant total drug concentration. 
 
 
4.2 Partition Coefficient by 19F NMR Spectroscopy 
The use of 19F NMR spectroscopy to determine the partition coefficient of a drug has 
relevant advantages. Since it has a large chemical shift (δ) range with high sensitivity, it 
is easy to measure the chemical shift changes induced by the drug interaction with the 
lipid bilayer. Moreover, 19F is not present in membranes so the 19F NMR signal can be 
measured without interference of background signals. [60-62] 
2) 
3) 
4) 
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The magnetic environment of a drug incorporated on a lipid bilayer is different from that 
of the drug in an aqueous phase. Based on this fact, Omran, A. et al developed a 
simple 19F NMR spectrometric method to determine the Kp of fluorinated drugs from its 
19F chemical shift change. [60] 
If the exchange rate of the drug between lipid and water phases is fast enough at the 
time scale of 19F NMR, the observed chemical sift (    ) of the 
19F signal can be 
expressed as: 
                   
 
Where    and    are the 
19F chemical shifts of the drug in the lipid and water phase, 
respectively. Therefore,    and    are constant values. 
Considering that             and            , fraction of drug on the lipid 
phase can be shown as: 
    
    
  
  
     
 
 
Since   
    
    
 
    
    
  , Kp can be calculated from the difference between the 
experimental 19F chemical shift of the drug before and after addition of lipid         
  ). Eq. 1) can be rewritten as: 
     
               
                  
 
 
Thereby, addition of increasing amounts of liposomes to a drug sample will allow the 
determination of Kp by the non-linear fit of     (       ).  
 
 
4.3 Partition Coefficient by Fluorescence Spectroscopy 
Kp determination by fluorescence spectroscopy can be based on two different 
approaches: One is based on the change in a fluorescence parameter of the drug 
before and after its incorporation in the membrane; the other is based on the change 
on a fluorescence property of a membrane probe upon incorporation of the drug in the 
membrane (with the proximity of the drug). [57] 
Once spx is a non-fluorescent fluoroquinolone, it was necessary to use a membrane 
probe, incorporated in the lipid bilayer, in order to determine the drug Kp. 
5) 
6) 
7) 
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The use of membrane fluorescent probes, whose fluorescence characteristics are 
sensitive to the surround environment, has been shown to be suited for studies with 
natural and model membranes [63-65]. Moreover, they can be used both to determine 
proximity relationships within the membrane and evaluate quantitatively the partition of 
a molecule within the bilayer [66]. 
 
4.3.1 Fluorescence Quenching 
The fluorescence quenching is the decrease of the fluorescence of a fluorophore by the 
presence of a quencher. This process can be either dynamic or static, depending on 
the nature of the interaction between the quencher and the fluorophore. In static 
quenching the quencher forms a non-fluorescent complex with the fluorophore. In 
dynamic quenching the interaction between the quencher and the fluorophore leads to 
the extinction of fluorescence during the fluorophore excitated state lifetime. After that, 
however, the fluorophore returns to its ground state, without any chemical alteration of 
either the quencher or the fluorophore. [43] 
The distinction between static and dynamic quenching can be performed by the 
determination of the fluorophore excitated state half-life time (  ). For dynamic 
quenching: 
 
  
 
 
  
, however for static quenching:   
 
  
  . 
 
4.3.2 Partition Coefficient using Fluorescence Membrane Probes 
The determination of the Kp of a non-fluorescent drug using membrane probes is based 
on a dynamic fluorescence quenching phenomenon, where the drug is the quencher 
and the membrane probe is the fluorophore. Since the fluorophore is specifically 
located inside the lipid bilayer, the partition of the drug in this bilayer will induce a 
decrease in the fluorescence of the fluorophore. This change, thereby, allows the 
quantification of the partition of the drug in the membrane.  
Considering the collisional interaction between the fluorophore (membrane probe) and 
the quencher (drug), the decrease in the fluorescence of the fluorophore can be related 
with the quencher concentration on the lipid phase using the Stern-Volmer equation 
[43, 67]: 
  
 
             
Where    and   are the fluorescence intensities of the sample in the absence and 
presence of the quencher, respectively.    is the fluorescence lifetime of the probe in 
8) 
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the absence of quencher and    is the bimolecular rate constant of quenching. [ ]  is 
the concentration of quencher (drug) in the lipid phase. 
Considering that the total concentration of quencher (     ) is shared between the 
aqueous and membrane phases according to the equation: 
 
                     
 
Where   ,    and    are the total volume, volume of the lipidic phase and volume of the 
aqueous phase, respectively. [ ]  is the concentration of quencher in the aqueous 
phase. 
Therefore, considering that Kp is the ratio between the concentration of drug in the 
membrane and the concentration of drug in the aqueous phase (   
   
  
   
  
⁄ ) and    
is the lipid volume fraction defined as     ⁄ ,      can be defined as: [43, 67] 
 
      
      
     (    )
 
 
 
 
Then eq. 8) can be substituted, obtaining: 
 
  
 
      
          
Where: 
 
  
       (
 
  
 
 
    
)  
 
    
  
 
The apparent quenching constant (  
   
) can be obtained from the slope of the Stern-
Volmer plot of  
  
 
  (    ), divided by    . 
Therefore, using n different liposome concentrations, the plot of 
 
  
     (  ) allows 
the determination of the Kp of the drug and the bimolecular quenching rate constant 
(  ). 
 
9) 
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12) 
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4.3.3 Inner-Filter Effect Correction 
When the sample contains species that absorb at the wavelength of excitation or 
emission of the fluorophore, the experimental results are affected by the inner filter 
effect (IFE). This phenomenon consists in a decrease in the fluorescence intensity 
emitted due to the absorption of exciting and/or emitted radiation by dissolved species, 
including the fluorophore itself. Generally, it is considered that the experimental results 
are affected by the IFE when the overall absorption of the sample at excitation and/or 
emission wavelength is higher than 0.1. [68, 69] 
The ratio between the observed fluorescence if only inner filter effect decreases the 
signal (IIFE) and the theoretical emission in the absence of any attenuation (F0) can be 
expressed as: [69] 
 
    
  
 ∫ ∫    (         )    
   
 
   
 
 
 
    
  
 
(         )(         )
           (  )
 
 
Where and   are the cuvette width and length (fig.11), respectively, and Aex and Aem 
are the sample absorbance at the excitation and emission wavelength, respectively. 
In many cases, a first order approximation of eq. 14) can be used, considering the 
mean emission intensity equal to the median intensity at the centre of the cuvette  
[43, 69, 70] : 
           
 (   
 
 
   
 
 
)
 
 
 
 
If beside the IFE, the drug also causes quenching, the corrected quenching ( ) can be 
expressed as: 
  
    
    
 
 
Where      is the experimentally observed drug emission and Q is the corrected 
quenching defined as   
  
         
. 
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Since spx absorbs at probe’s excitation wavelength it was necessary to correct for the 
inner filter effect at the excitation wavelength, for the partition experiments. Moreover, 
spx also absorbs at excitation and emission wavelength of OmpF tryptophans, so it 
was also necessary to correct for IFE, at both excitation and emission wavelength in 
the experiments of determination of the association constant between spx and OmpF. 
 
 
Fig. 11 Representation of the cuvette in the fluorimeter: White corresponds to the sample and grey to quartz glass.   
corresponds to the cuvette  length and  to the cuvette width. In the present study we used   4mm and   10 mm. 
 
4.3.4 N-AS Fluorescence Probes 
Fluorescence probes of the series of  -(9-anthroyloxy) stearic acids ( -AS) consist in 
molecules with an anthracene group linked to different positions in an alkyl chain 
(defined by the number  ) (fig.12).  
 -AS probes localization in lipid bilayers have been extensively studied, both in 
phospholipid model membranes or natural membranes [71-74]. These studies 
concluded that the anthracene group is disposed in the lipid bilayer according to the 
level of the carbon it is linked to, in the alkyl bilayer. Therefore, the 2-AS probe is the 
most superficial probe, located near the polar heads of the lipids, and 12-AS probe is 
the most internal probe. 
These probes have a higher solubility in lipid phase than in aqueous phase and, 
thereby, its preferential localized in the lipid phase. [75] 
This characteristic, along with the fact that their localization and fluorescent behaviour 
in the membrane is well-studied, make  -AS very suitable probes to be used in studies 
of drug localization and drug partition in membranes. 
In this study we chose to use the most superficial and the most internal probes (2-AS 
and 12-AS), in order to determine the Kp of spx by fluorescence spectroscopy.   
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Fig. 12 Chemical structure of the  -AS probes ( = 2,6,9,12). A corresponds to the anthracene group.  
 
 
 
5. Drug Interaction with a Membrane Protein 
– Association Constant 
The affinity of the interaction between two molecules can be represented by its 
association constant (Ka) that is simply the ratio at equilibrium of the “product” and 
“reactant” concentrations. 
Considering a 1:1 interaction between drug (D) and the OmpF protein (P): 
 
     ( )      ( )          ⁄ (  ) 
 
 Ka can be defined as: 
   
    
       
 
5.1 Association Constants by Fluorescence Spectroscopy 
As stated before, the fluorescence of a protein is, essentially, due to its tryptophan 
residues. Therefore, the association constant between a protein and a drug can be 
determined from the variation of the protein fluorescence upon addition of increasing 
amounts of drug. [43] 
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Previous studies show that the interaction between quinolones and OmpF protein 
results in a static fluorescence quenching phenomenon [76]. Therefore, the Ka between 
a quinolone and the OmpF protein can be calculated from the Stern-Volmer equation: 
 
  
 
          
 
Where    and   are the fluorescence intensities of the sample in the absence and 
presence of the quencher, respectively, and |Q| is the concentration of quencher 
(drug). 
Thereby, addition of increasing amounts of drug to proteoliposome suspension will 
allow the determination of Kp from the slope of the Stern-Volmer plot of:  
  
 
  (   ).  
 
 
5.2 Surface Plasmon Resonance  
Surface Plasmon resonance (SPR) is one of the most used techniques in the study of 
molecular interactions. The Biacore apparatus is the mainly used system for SPR 
experiments. [77, 78]  
SPR monitors the binding of an analyte to a ligand molecule from measuring the 
change in the refractive index of the medium in the vicinity of a metal surface 
(sensorchip). The ligand is attached on the surface of the sensor chip, while the analyte 
is pumped across the surface via a microfluidic system. Therefore, the interaction 
between the ligand and the analyte causes a change on the refractive index at the 
surface of the chip, which results in the increase of the SPR signal (resonance units 
(RU)). As SPR measures the mass concentration at the surface of the chip, the main 
advantage of this technique is that there is no need of labelling the molecules to study 
their interaction. [79, 80]  
There are a wide range of different sensor chips that allow the immobilization of 
different types of molecules, by different methods. For the study of the interaction 
between a molecule and model membranes the most used sensorchips are HPA and 
L1. HPA chip consists in an extremely hydrophobic surface where lipids tend to form a 
supported monolayer. On the other hand, L1 chip consists in lipophilic groups attached 
on the surface of a carboxymethylated dextran layer. Lipids can be retained in the 
surface of L1 chips either as intact liposomes [81, 82] or a lipid bilayer resulting from 
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fusion of captured liposomes [83]. Therefore, L1 chips are the most used in order to 
study the interaction between molecules and model membranes. [79, 81] 
Moreover, several studies showed that L1 chips have also the ability to retain intact 
proteoliposomes, maintaining the protein activity. [83, 84] 
Therefore, in the present work we improved our study of the interaction between spx 
and OmpF protein by using Surface Plasmon Resonance.   
 
 
 
 
 
Fig. 13 Direct attachment of liposomes with incorporated proteins on a L1 sensor chip. Two mechanisms are possible: 
A- fusion of the proteoliposomes and formation of a bilayer [85]; B- attachment of intact proteoliposomes [84]. 
 
5.2.1 Binding Analysis by Surface Plasmon Resonance 
5.2.1.1 Equilibrium Binding Analysis 
The Ka can be calculated directly from a SPR sensorgram by equilibrium binding 
analysis: [86] 
  
       
      
 
 
Where    is the dissociation constant,   is the SPR response measured in RUs and 
     is the maximum response.  
   value can be obtained from   , since    
 
  
. 
Therefore,   ,    and      values can be obtained from the non-linear curve fit of 
   (   )  
A 
B 
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5.2.1.2 Kinetic Analysis 
Kinetic analysis of SPR data allows the calculation of the affinity constant from the 
association rate constant (kon) and dissociation rate constant (koff) values. 
Considering that:  
   koff 
      (  ) 
    kon 
 
The relation between koff, kon and the SPR response over the time is described by the 
following equations: [86] 
 
Association :                
       
      
[   (            ) ] 
 
Dissociation:                   
       
 
Where    is the response over the time and    is the signal level at the beginning of 
dissociation. 
The Kd can be calculated from koff and kon, since: 
    
    
   
 
 
5.2.1.3 Affinity by Kinetics or Equilibrium Binding Analysis? 
Ideally, values determined from kinetics or equilibrium binding analysis should be the 
same. However, generally, different experimental data contain information that is 
applicable for a specific approach: kinetics analysis can be used for sensorgrams that 
contain kinetic information but do not necessarily reach steady state, while equilibrium 
binding analysis can be used for interaction where the kinetics is too fast to be 
measured with confidence but the steady-state is reached. [86] 
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Fig. 14 Sensorgrams that contain information that is applicable for a specific approach. A- Data that is suitable for 
kinetics analysis but does not reach steady-state. B- Data that reaches steady-state but it is too fast to resolve 
kinetics.[87] 
 
 
 
6. Objectives 
The main objective of this study is the improvement of the knowledge about 
sparfloxacin free or copper-complexed drug internalization in Gram – bacteria, in order 
to find new insights in the combat of bacteria resistance to this fluoroquinolone. 
Further objectives of this study were the use several techniques to determine the 
interaction of non-fluorescent drugs with membrane model systems: 
- 19F NMR spectroscopy and fluorescence spectroscopy with fluorescent probes 
in the determination of partition coefficients in liposomes and, 
- Surface Plasmon Resonance in the study of fluoroquinolone binding to Gram – 
natural model membrane/OmpF proteoliposomes. 
 
 
 
 
 
 
 
 
 
A B 
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II. MATERIAL AND METHODS 
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1. Reagents and Solutions 
Sparfloxacin (>98,0%) was provided by Fluka, and stored in the dark, at room 
temperature. All lipids were provided by Avanti Polar Lipids and stored at -18°C in the 
freezer. Chloroform (CHCl3, Reagent plus®, purity  99,8%) used in the formation of 
the lipidic films was provided by Sigma. HEPES buffer solution (10 mmol.dm-3 (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0,1 mol.dm-3 NaCl) was 
prepared by weight of HEPES hemisodium salt (purity  99%) and Sodium chloride 
both provided by Sigma. 
Fluorescent probes, (±)-2-(9-Anthroiloxy) stearic acid (2-AS) from Molecular Probes 
and (±)-12-(9-Anthroiloxy) stearic acid (12-AS) from Sigma were dissolved in ethanol 
absolute PA from Panreac and stored at -18°C in the freezer. Deuterium oxide (D2O, 
99,90%D), used in the 19F-NMR experiments, was provided by euriso-top and stored in 
the desiccator, at room temperature. Spermine, used as a positive control (OmpF 
channel blocker) in SPR experiments, was provided by sigma and stored at 6ºC. 
OmpF protein ( 1 mg.ml-1, 1% o-POE), used to produce proteoliposomes, was either 
offered from Professor Mathias Winterhalter, from Jacobs University, Bremen or Doctor 
Ricardo Franco, from Universidade Nova de Lisboa, Caparica. It was stored in small 
aliquots ( 1mL) at -18°C in the freezer, protected from light. n-octyl-oligo-oxyethylene 
(o-POE) detergent from Bachem AG and bio-beads SM-2 (polystyrene adsorption 
spheres) from Bio-Rad were also used in the proteoliposomes production. o-POE 
detergent was stored at -18°C in the freezer, protected from light and bio-beads were 
stored in the desiccator, at room temperature. 
OmpF concentration was determined by the bicinchoninic acid assay, using bovine 
serum Albumin (BSA) as a standard. Bicinchoninic Acid Kit (BCA-1) used was provided 
by Sigma and composed by Bicinchoninic Acid solution, Copper(II) sulphate solution 
and protein standard solution (BSA 1 mg.ml-1).  
 
 
2. Instrumentation 
Weighing was carried out using semi-analytical Mettler AE 160 scale (± 2x10-4g) and 
analytical Mettler AT 201 scale (± 2x10-5g).  HEPES buffer solution pH was measured 
using a Crison GLP 22+ pH & Ion-meter, with a pH electrode also from Crison. 
Large unilamellar liposomal suspensions (LUVs) were produced by extrusion of 
Multilamellar liposomal suspensions (MLVs) using a Lipex Biomembranes Extruder 
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with Whatman polycarbonate filters. Extrusions were performed above the transition 
temperature of the lipid using a Clifton thermostatic water bath linked to the extruder. 
The size of the liposomal and proteoliposomal particles was determined by dynamic 
light scattering using Zeta Sizer Nano ZS from Malvern Instruments.  
UV-vis spectroscopic studies and determination of OmpF concentration assay were 
carried out using a Shimadzu spectrophotometer UV-3600 and temperature controlled 
with Shimadzu Tcc-Controller. Fluorescence spectroscopy studies were accomplished 
using a spectrofluorometer Cary Elipse from Varian, equipped with a temperature 
controller Single Cell Peltier Accessory from Varian.  
NMR spectroscopy studies were performed using a Bruker Avance III 400 NMR 
spectrometer, equipped with internal temperature control. 
SPR studies were accomplished using a Biacore X100 apparatus, equipped with 
internal temperature control. 
 
 
3. Liposomes Preparation 
LUVs were produced by hydration and extrusion method [88]. A chloroform solution of 
E. coli total lipid extract or PE:PG (75:25) was dried under a flow of argon, leading to 
the formation of a thin lipidic film that was kept under vacuum for 3h to remove all the 
organic solvent traces. MLVs were obtained by hydration of the film with HEPES buffer 
solution, followed by vortexing to ensure de dilution of all the lipidic film. Five cycles of 
freezing with liquid nitrogen and thawing with a boiling water bath were then applied to 
the MLVs suspension. Afterwards, the suspension was placed for 30 minutes in a 
water bath, above the transition temperature of the lipid. LUVs suspension wit  100nm 
diameter was then produced by extrusion of the MLV suspension, through 100nm 
polycarbonate filters (10 times). Extrusion was conducted under a stream of Argon with 
230 bar pressure and above the transition temperature of the lipids (70°C for E. coli 
total lipid extract and 37°C for PE:PG). Size distribution of the LUVs suspension was 
determined, at 37°C, using dynamic light scattering (DLS)  
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3.1 Preparation of Liposomes with Fluorescent Probes 
Fluorescent probes (±)-12-(9-anthroyloxi) stearic acid (12-AS) and (±)-2-(9-anthroyloxi) 
stearic acid (2-AS) were inserted in the liposomes to determine the partition coefficient 
of the drug by spectrofluorimetry. Probes were dissolved in a suitable quantity of 
ethanol and added to the lipid in order to achieve a final lipid:probe ratio of 100:1 and a 
final %(v/v) of ethanol of 1%. 
For PE/PG (75:25) system, probes were inserted in the liposomes by incubation [89]. In 
this method a suitable quantity of probe was added to the LUV’s suspension, prepared 
as described above, (final lipid:probe ratio of 100:1). The probe was then mixed with 
the LUVs and incubated for 30 minutes above the transition temperature of the lipid.  
For E.coli lipid extract system probes were inserted in the lipid bilayer by incorporation 
[90]. In this procedure an appropriate quantity of probe solution was added to the lipid 
previously dissolved in chloroform (final lipid:probe ratio of 100:1). Then the lipid film 
was produced by drying under a flow of argon followed by vacuum and liposomes were 
produced as described above.  
 
 
4. Proteoliposome Preparation 
4.1 Quantification of OmpF Protein 
OmpF concentration was determined by the bicinchoninic acid assay that allows the 
determination of protein concentration in samples, using standard solutions of bovine 
serum albumin (BSA) to produce a calibration curve. [91] 
Briefly, six standard solutions of BSA with known concentration (0.100, 0.200, 0.300, 
0.400, 0.500, 0.600 mg.mL-1) were prepared by dilution of a standard concentrated 
solution of 1.00 mg.ml-1. Two OmpF samples with different concentration and a blank 
containing just HEPES buffer were also prepared. Then 2 ml of “work reagent”, 
composed by 50 parts of Bicinchoninic Acid solution to 3 parts of Copper (II) sulphate 
solution, were added to each glass tube containing 0.1 ml of each standard, sample or 
blank solution. Glass tubes were then incubated for 3h at 37°C and then left at room 
temperature to decrease and stabilize the temperature. After temperature stabilization 
the absorbance of the solutions at 562 nm was determined. Duplicates of all standard 
and sample solutions were also prepared. 
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4.2 Reconstitution of OmpF Protein in LUVs 
In order to guarantee a unidirectional and efficient insertion of the protein in the 
liposomes, OmpF was reconstituted in preformed LUVs, with detergent concentration 
below but near the CMC of formation of Lipid-detergent mixed micelles. [52] 
 The insertion of OmpF protein in the liposomes to a final ratio OmpF:lipid of 1:1000 
was performed by direct incorporation, using a well-established methodology[92, 93]. 
Briefly, 0.85 mg of OmpF protein (1% o-POE) and a given volume of liposome 
suspension were mixed in order to obtain a concentration of 2 mmol.dm-3 of lipid in a 
final volume of 4ml of proteoliposomes. Then a buffer solution of o-POE (1% v/v) was 
added in order to obtain an o-POE concentration near (but below) the critical lipid/o-
POE mixed micelle concentration and HEPES buffer was added to obtain a final 
volume of 4 ml. The sample was then slowly stirred at room temperature for 20 
minutes, protected from light. Afterwards, it was placed in an ice bath for 1 hour and a 
temperature shock with boiling water was given after 30 minutes of incubation in ice. 
Polystyrene beads (bio-beads SM-2) were added twice (75 mg/ml) in order to remove 
all traces of detergent. Firstly, the sample with the bio-beads was incubated at room 
temperature for 3h, under slow stirring and protected from light. Then the supernatant 
was placed in a new vial with fresh bio-beads and was incubated over-night, in ice and 
with gentle stirring. After removing bio-beads from the sample, it was subjected to 5 
cycles of freezing with liquid nitrogen and thawing in a boiling water bath, followed by 
incubation for 30 minutes above the transition temperature of the lipid in order to 
ensure temperature stabilization. Extrusion and final size distribution measurement for 
the proteoliposomes was then performed as described before for the liposomes.  
 
 
5. Determination of Sparfloxacin Partition 
Coefficient 
Lambert-beer law for sparfloxacin was traced using ten spx standard-solutions 
(concentration between the range 3-38 µmol.mL
-1
), rigorously prepared in HEPES buffer 
from dilution of a standard solution of 38.226 µmol.mL
-1
. Spectra were obtained for a 
wavelength range of 225 to 450 nm. 
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5.1 Determination of Partition Coefficient by UV-vis 
Spectroscopy 
Determination of the partition coefficient of spx in E.coli total lipid extract by UV-vis 
spectroscopy was carried out by measuring the change in the absorbance of the 
different samples with a constant drug concentration and an increasing lipid 
concentration. Spx solution of 22.0 µmol.dm-3 (concentration corresponding to an 
absorbance of around 0.5) and liposome suspensions from 0.1 mmol.dm-3 to 1 
mmol.dm-3 were used in this experiments. Two groups of 11 tubes were prepared, one 
containing samples (drug solution and liposome suspensions), and other containing 
just lipid suspensions with the same concentration of the corresponding sample that 
were used as a reference to correct lipid light dispersion from the sample absorbance. 
The vials were then vortexed, incubated at 37°C for 30 minutes and the absorbance 
spectra of the samples and references was traced (from 225 to 450 nm). Absorbance 
spectra were obtained at 37°C and using HEPES as blank. Corrected spectra were 
then determined by subtracting the reference spectrum to the respective sample 
spectrum. Smoothed spectra were calculated using Savitzy-Golay algorithm and first 
and second derivate calculated using Origin pro 8.0.     
 
5.2 Determination of Partition Coefficient by 19F Nuclear 
Magnetic Resonance 
Partition coefficient of spx in E.coli total lipid extract was determined by 19F NMR by 
measuring the variations in 19F chemical shifts upon addition of increasing amounts of 
liposome suspensions to aqueous solutions of drug. Seven samples were prepared, 
containing a fixed spx concentration (175 µmol.dm-3) and increasing liposome 
amounts, from 1 to 10 mmol.dm-3. Samples were then vortexed, incubated at 37°C for 
30 minutes and vortexed again before the measures. A single 5 mm NMR tube was 
used, in order to decrease signal variations, and the different samples were inserted 
and removed from the tube using a special big glass pipette and samples were read 
from the lowest lipid concentration to the higher in order to avoid measurement errors 
due to the previous sample. A capillary containing KF in D2O was inserted in the NMR 
tube and used during the experiments as a reference Fluoride signal and to provide the 
deuterium lock. 19F NMR spectra were traced at 376.52 MHz, at 37°C and using FID 
accumulations between 1k and 7k in order to ensure a good signal to noise ratio. 
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19F NMR data was analysed using the Topspin 3.1 software. 
 
5.3 Determination of Partition Coefficient by 
Spectrofluorimetry 
Determination of the partition coefficient of spx in E.coli total lipid extract and PE/PG 
(75:25) by spectrofluorimetry was carried out using fluorescence probes (12-AS and 2-
AS) incorporated in liposome suspensions with different lipid and measuring the 
quenching upon addition of increasing amounts of drug. Liposomes were prepared with 
fluorescent probes as described above (by incorporation in E.coli total system and 
incubation in PE/PG system). 9 tubes containing increasing spx concentration (from 0 
µmol.dm-3 to 80 µmol.dm-3) were prepared for each batch containing a constant lipid 
concentration (from 100 µmol.dm-3 to 600 µmol.dm-3). The vials were then vortexed, 
incubated at 37°C for 30 minutes and vortexed again before the measures. 
Fluorescence measurements were carried out using quartz cells, with a speed of 120 
nm/min with 3 readings, data interval of 1 nm. Excitation slit of 5nm and emission slit of 
10 nm were used to the experiment with 100 µmol.dm-3 of lipid and excitation and 
emission slits of 5nm were used to the experiments with higher lipid concentration. 
Fluorescence spectra were obtained at an excitation wavelength of 363 nm and 
emission in the range 380 nm to 550nm. All samples were kept at 37°C during the 
experiments and fluorescence measurements were also performed at this temperature.  
Fluorescence data was analysed using the program Origin 8.0. 
 
 
6. Determination of Metal Complex 
[Cu(II)/spx/phen] Partition Coefficient 
Lambert-beer law for [Cu(II)/spx/phen] was traced using ten standard-solutions with 
concentration in the range [4-30 µmol.mL
-1
]. These standard-solutions were rigorously 
prepared in HEPES buffer from dilution of a standard solution of 48.420 µmol.mL
-1
. 
Absorption spectra were obtained for a wavelength range of 225 to 450 nm. 
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6.1 Determination of Partition coefficient by Spectrofluorimetry 
Partition coefficient of the complex [Cu(II)/spx/phen] in E.coli total extract liposomes 
was determined by spectrofluorimetry using fluorescence probe (12-AS) incorporated 
in liposome suspensions using the same approach described above for spx. The 
[Cu(II)/spx/phen] solution concentration range used in these experiments was from 0 to 
50  µmol.dm-3 . 
 
 
7. Determination of Association Constants 
7.1 Determination of Association Constant by 
Spectrofluorimetry 
Determination of the association constants of spx and [Cu(II)/spx/phen] with 
OmpF/E.coli total extract proteoliposomes was carried out by measuring the 
fluorescence quenching upon addition of increasing amounts of drug to the 
proteoliposome suspension. 
Proteoliposomes suspension (1.0 mL) of 1 mmol.dm-3 lipid : 1 μmol.dm-3 OmpF was 
prepared and put in a quartz cell, with stirring. Emission spectrum of the sample was 
obtained. Ten additions of small amounts of drug were added, in order to have a spx 
concentration range from 0 to 15 µmol.dm-3 and a [Cu(II)/spx/phen] concentration 
range from 0 to 9 µmol.dm-3. For each addition emission spectra were obtained after 
the sample being incubated for a period of 5 minutes with stirring. Fluorescence 
spectra were obtained at an excitation wavelength of 290 nm and emission wavelength 
between 300 to 400nm. Excitation and emission slit of 5nm, three readings with scan 
speed of 120 nm/min, data interval of 1 nm and temperature of 37°C were used in the 
experiments. Fluorescence intensity of the sample was corrected for the dilution 
caused by each addition of drug, according to the expression:  
             
(        )
  
                 
Where              is the fluorescence intensity corrected for dilution;                 is the 
fluorescence intensity obtained;     is the initial volume of proteoliposomes suspension 
and       is the added volume of drug. 
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Fluorescence data was analysed using the program Origin 8.0 and Ka values are 
calculated from analysis of three independent experiments. 
 
7.2 Determination of Association Constant by Surface 
Plasmon Resonance  
Determination of the Ka of spx and [Cu(II)/spx/phen] with OmpF/E.coli natural lipid 
extract proteoliposomes was carried out by SPR technology. Proteoliposomes were 
immobilized in the sensorchip, using the L1 sensorchip and spx, free or complexed 
drug, or positive control (spermine) were used as the running analyte. All SPR 
experiments were carried out at physiological pH, using HEPES buffer (pH=7.4) and 
37.0°C. [83-86, 94] 
In all experiments, prior to use, the L1 chip surface was washed with a conditioning 
cycle, consisting on a double injection of 3-[(3-cholamidopropyl)dimethylamonio]-1-
propanesulfonate (CHAPS), 20 mmol.dm-3, at a flow rate of 5 µl/min for 4 min, followed 
by running buffer (HEPES) injection at a flow rate of 5 µl/min for 4 min. 
SPR data was analysed by Biacore X100 control software and Origin 8.0. 
 
7.2.1 Proteoliposome Deposition 
Experiments of proteoliposome deposition in the L1 sensorchip using different 
experimental conditions were carried out in order to find the best experimental 
conditions to be used in subsequent binding experiments.  
A multi-capture cycle was performed, using different proteoliposome concentrations, 
different contact times and with or without using NaOH for enhancement of the SPR 
signal. 
Each capture cycle was performed by injecting proteoliposomes (1 or 2 mmol.dm-3) at a 
flow rate of 2 µl/min for 2700 or 2500 s, followed by an injection of HEPES at a flow 
rate of 50 µl/min for 100 s. Afterwards a double injection of either NaOH 10 mmol.dm-3 
or HEPES buffer, at flow rate 50 µl/min for 60 s was performed. 
 
7.2.2 Binding Experiments 
The proteoliposomes capture cycle was performed by injecting proteoliposomes 
suspension (2 mmol.dm-3) in flow path 2 (and liposomes 2 mmol.dm-3 in flow path 1 at 
the same time) at a flow rate of 2 µl/min for 2700 s, followed by an injection of HEPES 
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(flow rate of 50 µl/min for 100 s), an injection of NaOH 10 mmol.dm-3 (flow rate of 50 
µl/min for 60 s), three injections of HEPES (flow rate of 50 µl/min for 100 s) and, finally, 
two injections of HEPES (flow rate of 10 µl/min for 500  s).  
Drug binding and dissociation experiments were then performed, using 7 cycles with a 
mutli-binding approach. Each cycle consists in a first injection of HEPES (flow rate of 5 
µl/min for 500 s), followed by spx, [Cu(II)/spx/phen] or spermine injection at a flow rate 
of 30 µl/min, contact time 180s, dissociation time 600s and, finally, HEPES injection at 
a flow rate of 10 µl/min for 230 s. 
In the end a regeneration cycle was performed: two injections of CHAPS, at a flow rate 
of 10 µl/min for 150 s, followed by two HEPES injections at a flow rate of 10 µl/min for 
150 s. Final results, showing the specific interaction of the drug with the OmpF protein 
were then obtained by the difference of Flow path 2- Flow path 1 signal.                 
Some binding experiments were also performed using exactly the same experimental 
procedure but keeping L1 nude chip in flow path 1. Flow path 1 signal quantify possible 
interaction between the analyte and the sensorchip and, thus final result was also 
obtained by the difference of Flow path 2- Flow path 1 signal. 
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III. RESULTS AND DISCUSSION 
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1. Partition Coefficient of Sparfloxacin 
Determination of partition coefficient enables a quantitative evaluation of the interaction 
of a drug with a microheterogeneous system [57]. Thus, this is the first step in the study 
of the interaction of the drug with a model membrane system.  
Interaction between drugs and membrane phospholipids has traditionally been 
determined by the partition coefficient of the drug between octanol and water (Kow). 
However this parameter does not  characterize the real interaction between drugs and 
lipids in biological membranes since it does not includes the electrostatic interactions 
with the polar groups of the lipids [95].  Therefore, liposomes are the most 
advantageous model of biological membranes to be used in these studies since they 
can mimic the chemical and structural environment of bacterial membrane but lack 
their transport machinery, providing a more realistic description of the drug distribution 
between the aqueous and membrane phases [49].  
For that reason the first step of our work was the determination of the partition 
coefficient of sparfloxacin in LUVs that mimic E. coli outer membrane.  E.coli 
membrane is a very complex system with a large variety of lipids, some of them still 
unrevealed. Thus, in this study we used E.coli total natural lipid extract as the main 
model membrane system to completely mimic E.coli membrane. However, it is also 
known that E.coli membrane is mostly composed of phosphatidylethanolamine (PE), 
phosphatidylglycerol (PG) and cardiolipin (CL), so we also used PE/PG (75:25) as a 
simpler membrane model, with the lipid proportions used as described in literature [95, 
96].  
Since spx is a non-fluorescent drug, the simplest and direct determination of the 
partition constant by fluorescence spectroscopy was not possible to apply. Therefore, 
multiple different techniques were tested in order to determine the Kp value of the drug: 
19F NMR spectroscopy, UV-visible absorption spectroscopy and fluorescence 
spectroscopy in the presence of a fluorescence probe. 
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1.1 Determination of Partition Coefficient by UV-vis 
Spectroscopy 
1.1.1 Lambert-Beer Law of Sparfloxacin  
The first step of our work was to find a suitable drug concentration to be used in the 
partition studies.  
 
Fig. 15 Absorption spectra of spx solutions in HEPES buffer (pH 7.4) with increasing spx concentration (3.058, 7.645, 
11.468, 15.291, 19.113, 22.936, 26.758, 30.581 and 38.226 µmol.dm
-3
) at 37.0°C. 
In order to find a suitable spx concentration to UV-vis spectroscopy studies we first 
determined the concentration range in which the Lambert-Beer law is valid for spx at its 
maximum absorption wavelength (289 nm). Using the data collected from the 
linearization of spx absorbance at its maximum wavelength (fig.16), we conclude that 
Lambert-Beer law is valid for spx in the concentration range [3 – 38 µmol.dm-3] and ε of 
spx at this wavelength is 0.0213 x 106 mol-1.cm-1. 
Therefore, for UV-vis spectroscopy studies we chose a spx concentration 
corresponding to an absorbance of about 0.5 (  22 μmol.dm-3 ). 
 
 
Fig. 16 Lambert-Beer law for spx solutions (same concentration as fig.15) at its maximum absorption wavelength (289 
nm). 
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1.1.2 Partition of Sparfloxacin with E.coli Total Lipid Extract 
Liposomes by UV-vis Spectroscopy 
UV-vis spectroscopy has been widely used to the determination of the partition 
coefficient of non-fluorescent drugs with liposomes, based on the change of drug 
absorption parameter upon its incorporation into lipid membranes. However, strong 
background signals of liposome light scattering interfere on the correct Kp calculation 
by this method. Firstly, scattering from the lipid suspension should be subtracted from 
the final absorbance of the sample. Moreover, liposome light scattering is usually 
eliminated by the use of derivative spectroscopy, which provides also a better 
resolution of the overlapped bands [96].  
However, in our study we were unable to completely eliminate the lipid light scattering. 
A possible explanation is that E.coli lipid extract is a natural heterogeneous lipid, which 
has a light scattering substantially higher than the observed for synthetic lipids. 
Nevertheless, the application of the third derivate decreased substantially the 
scattering at 298 nm (fig.18 C).  
 
Fig. 17 Absorption spectra of E.coli lipid extract liposomes suspensions with increasing concentration (0.100, 0.201, 
0.301, 0.402, 0.502, 0.602, 0.703, 0.803, 0.904, 1.00 mmol.dm
-3
) in HEPES buffer (pH 7.4).  
 
 
 
Fig. 18 (A) First-derivate; (B) second-derivate; (C) third-derivate of the absorption spectra of E.coli lipid extract liposome 
suspensions in HEPES buffer (pH 7.4). 
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Applying the third derivative to 298 nm, that corresponds to the maximum wavelength, 
it was possible to eliminate the scattering and determine the partition of the drug. 
Fig.19 shows the variation in the absorption spectrum of spx upon addition of 
increasing amounts of drug and fig.20 is the third-derivate of these spectra.  
 
Fig. 19 Absorption spectra of spx (22.2 μmol.dm
-3 
) in HEPES buffer (pH 7,4) in absence and presence of increasing 
amounts of E.coli liposomes (0.1 to 1 mmol.dm
-3
 – exact concentrations referred in fig. 17). 
 
Fig. 20 Third-derivate of the absorption spectra of spx (22.2 μmol.dm
-3
) in HEPES buffer (pH 7,4) in absence and 
presence of increasing amounts of E.coli liposomes (0.1 to 1 mmol.dm
-3
 - exact concentrations referred in fig.17 ) . 
 
Kp of spx in E.coli liposomes was calculated from the variation of the third derivate of 
sample absorbance (upon subtraction of respective references) with increasing lipid 
concentration: ΔA3d=f(|Lipid|) (fig.21). Log(Kp) calculated both by non-linear fit and 
Lineweaver-Burk fit are listed in table 2.  
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Fig. 21 Fit of the difference between the third-derivate absorbance at 298 nm of spx in absence and presence of 
increasing amounts of E.coli liposomes. (A) Fit using non-linear least-squares method [eq 4)]. (B) Fit using Lineweaver-
Burk method.  Points shown in red were not used for the linear fit. 
 
Table 2 Partition coefficient of sparfloxacin in E.coli total liposomes calculated using both non-linear curve fit and 
Lineweaver-Burk fit. 
 Non-linear curve fit Linewear-burk fit 
Log(Kp) 3.4 ±0.4 3.9 ±0.1 
 
 
However, these results required confirmation from other techniques because, 
considering the three experiments performed, it was only possible to determine, 
accurately, the Kp in one of the experiments 
 
1.2 Determination of Partition Coefficient by Nuclear Magnetic 
Resonance (NMR) Spectroscopy  
1.2.1 Partition of Sparfloxacin with E.coli Total Lipid Extract 
Liposomes by NMR Spectroscopy 
Unlike UV-vis spectroscopy, 1H NMR has not been largely used to the determination of 
the partition coefficient of drugs, mainly because of the strong background signal from 
the lipid carbonated chains. However, since spx has fluorides in its structure, it is 
possible to study the interaction between this drug and the liposomes by 19F NMR 
spectroscopy. The use of 19F NMR spectroscopy has numerous advantages including 
the fact that there is no background signal from the water, buffer or lipid molecules 
disturbing the 19F measurements and 19F NMR spectroscopy has a large chemical sift 
range and high sensitivity [97] [60]. 
A B 
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Since the magnetic environment of the free drug is different from that of the drug 
incorporated in the liposomes, chemical shift (δ) of 19F signal of the drug in the two 
environments is different.  Therefore the determination of the Kp by this method relied 
on the measure of the variation of the chemical shift (Δδ) of the drug upon addition of 
increasing amounts of liposomes to the drug solution. An example of the 19F NMR 
spectra of spx containing increasing amounts of E.coli total lipid extract liposomes is 
represented in fig.22. The complete 19F NMR spectrum of spx contains two single 19F 
signals corresponding to the 2 fluorides present in spx molecular structure. As shown in 
fig.22, upon addition of lipid, the 19F NMR spectra of the sample showed broadening 
and a variation in the chemical shift of both 19F signal as a result of the interaction 
between the drug and the lipid bilayer. Moreover, there is only a single signal 
correspondent to each fluoride which proofs that the exchange rate between free and 
partitioned states of the drug is fast enough for the 19F NMR time scale.  
When we analysed each 19F signal singly, it is important to refer that only the signal 
correspondent to -151 ppm showed a pattern upfield shift. Thus, only this signal was 
used for subsequent determination of Kp. A possible explanation for this is the 
excessive signal broadening of the other 19F signal that did not enable a correct 
determination of the pick signal. Moreover the position of the two fluorides in spx 
molecule is different and thus the environment around them upon interaction with the 
lipid can also be different. One of the fluorides can experiment a more polar 
environment than the other which can also explain their different behaviour. 
Thereby focusing on the analysis of the 19F signal correspondent to -151 ppm we can 
see by fig.22 that it shows an upfield shift upon increase of LUV amount.  
  
 
Fig. 22 
19
F NMR spectra of spx (300 µmol.dm
-3
), in HEPES buffer (pH 7.4) in absence and presence of increasing 
amounts of E.coli liposomes (1.0 to 8.0 mmol.dm
-3
). 
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19F chemical shift for each spectrum was measured (δobs) and the difference between 
each δobs and the chemical of the free drug (δ0) was calculated (Δδ). Kp and Δδmáx were 
then calculated by non-linear least-squares method and Lineweaver-Burk method 
(fig.23) and their values are listed in table 3. 
 
Fig. 23  Fit of the 
19
F chemical shift variation Δδ of spx in absence and presence of increasing amounts of E.coli 
liposomes. (A) Fit using non-linear least-squares method [eq. 7)]. (B) Fit using Lineweaver-Burk method. Points shown 
in red were not used for the fit. 
 
 
Table 3 Δδ max and partition coefficient of sparfloxacin in E.coli total liposomes calculated using non-linear curve fit and 
Lineweaver-Burk fit. 
 Non-linear curve fit Lineweaver-Burk fit 
Log(Kp) 3.4 ±0.1 3.6 ±0.1 
Δδmáx /ppm 0.17 ±0.05 0.12 ±0.02 
 
 
1.3 Determination of Partition Coefficient by Fluorescence 
Spectroscopy 
1.3.1 Sparfloxacin Lambert-Beer Law 
For the fluorescence studies it is also important to determine the absorption of the 
sample at the excitation and emission wavelength. This determination is essential to 
find the suitable range of spx concentration to be used in the assays and to account for 
possible inner filter effects. Since spx is a non-fluorescent molecule, we used a 
fluorescent probe inserted in the lipid bilayer in order to determine the Kp of the drug. 
Therefore, we determined the range of concentration at which the Lambert-Beer law of 
spx is valid at probe’s excitation wavelength (363 nm) (fig.24). Analysing the linear plot 
we found that the suitable spx concentration to be used in fluorescence studies was [0-
A B 
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80 μmol.dm-3]. Moreover, it is important to refer that the drug’s absorption at probe’s 
emission wavelength (455-460 nm) was non-relevant being needless to correct for 
inner filter effect at this wavelength. Fig.25 shows the superimposed spectra of 
excitation and emission of 2-AS and 12-AS probes inserted in E.coli natural lipid extract 
liposomes and the absorption spectrum of spx. 
 
Fig. 24  Lambert-Beer law for spx solutions (0.100, 0.201, 0.301, 0.402, 0.502, 0.602, 0.703, 0.803, 0.904, 1.00 
mmol.dm
-3 
) in HEPES buffer (pH=7.4) at n-AS probes excitation wavelength (363 nm). 
 
 
 
 
Fig. 25 Overlap of spx absorption spectrum (38.226 µmol.dm
-3
) and 2-AS/12-AS/E.coli total lipid extract liposome 
fluorescence spectra (700 µmol.dm
-3 
liposome/7 µmol.dm
-3 
probe). A- Superimposed spectra of spx absorption and 2-AS 
and 12-AS excitation. B – Superimposed spectra of spx absorption and 2-AS and 12-AS fluorescence emission. 
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1.3.2 Partition of Sparfloxacin with E.coli Total Lipid Extract 
Liposomes using Fluorescent Probes Incorporated in the Lipid 
Bilayer  
Fluorescence spectroscopy has been extensively used to calculate the partition 
coefficient between drugs and model membranes. However, for most cases, this 
methodology uses the difference in a fluorescence parameter of the drug, before and 
after the incorporation in the membrane in order to calculate the partition coefficient of 
the drug [57]. Since spx is a non-fluorescent drug we had to use a different approach 
that uses the change on a fluorescent property of a membrane probe caused by the 
incorporation of the drug in order to calculate the partition coefficient. This methodology 
is based on fluorescence quenching, since the drug incorporation causes a decrease in 
the fluorescence intensity of the probe, acting as a “quencher”. Therefore, the decrease 
of the fluorescence intensity of the probe depends on the average number of drug 
molecules in its vicinity [57]. 
In this study, we tried to use two different probes of the series n-(9-anthroyloxy) stearic 
acids (n-AS), 2-AS and 12-AS, in order to calculate the partition of spx. These probes 
were chosen since, despite their similar structure, they have very different location in 
the lipid bilayer. 2-AS is located in the membrane interface and 12-AS is is located in 
the bilayer centre [71] [89]. Therefore, the use of these two different probes will not only 
allow the calculation of the partition of the drug but also could provide information about 
the location of the drug in the membrane bilayer. 
The quenching data was analysed as described by Lakowicz [98]. Apparent quenching 
rate constants (kq
app) of the batches with different lipid concentration were determined 
from the Stern-Volmer plots. Kp and bimolecular quenching rate constant (kq) were then 
determined by the plot of (kq
app)-1 versus the lipid volume fraction (αm). 
 
1.3.2.1 Partition Obtained with 2-AS 
As described previously, we studied the interaction of spx with E.coli total lipid extract 
using two different n-AS probes. Firstly, we used the most superficial probe, 2-AS. As 
expected, the increasing of drug amount causes a quenching effect that is related with 
the drug incorporation in the lipid bilayer. Fig.26 shows the emission spectra of the lipid 
without drug and with increasing drug concentration for the highest lipid concentration 
used (700µmol.dm-3).  
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Fig. 26 Fluorescence spectra of 2-AS/E.coli total lipid extract liposomes (700 µmol.dm
-3
)  in HEPES buffer (pH 7,4) in 
absence and presence of increasing amounts of spx (10.0, 20.0, 30.0, 40.0, 50.0, 60.0, 70.0, 80.0 µmol.dm
-3
). 
 
Stern-Volmer plots were then obtained using the fluorescence intensity for the λmáx of 
emission and after correction for the inner filter effect (eq.15 and eq.16) at probe’s 
excitation wavelenght. Fig.27 shows the Stern-Volmer plots for the different lipid 
concentration used (100, 250, 500 and 700µmol.dm-3). Table 4 shows the kq
app values 
calculated from the Stern-Volmer plots for each lipid concentration, considering that    
of 2-AS probe is 5.01 ns [90].  
 
Fig. 27 Stern-Volmer plot of I0/I=f(|spx|), for the different lipid concentration used (100, 200, 500, 700 µmol.dm
-3
). Fit of 
eq 11). 
 
Table 4 List of the different lipid concentration and correspondent αm used and the Kq
app
 obtained from the Stern-Volmer 
plot of I0/I=f(|spx|). 
|Lipid| / µmol.dm-3 αm / (x10
-3) mg.ml-1 kq
app / (x1012) mol-1.dm3.s-1 
100 0.096 0.885 
250 0.24 1.03 
500 0.48 1.06 
700 0.68 1.21 
 
|spx| 
 80 µmol.dm-3   
0 µmol.dm-3 
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As describe by Lakowicz it was expected a higher quenching effect upon decreasing 
the lipid concentration [43]. This is explained by the fact that for lower lipid 
concentration there is less lipid into which the drug can partition. Therefore, for lower 
lipid concentration, the addition of the same amount of quencher would result in a 
higher quencher amount in the lipid membrane. However, using this probe we obtained 
an unexpected result. As exposed in the plots in fig.27, quenching effect increases with 
the increase on lipid concentration and thus, apparent bimolecular constant also 
increases with the increase in lipid concentration. This result does not allow the 
determination of the Kp of spx using this probe, since the plot of 1/kq
app =f(αm) has a 
negative slope (fig.28), giving a negative Kp value. To explain this result, it is important 
to refer that this probe is referred as a peculiar member of these family of probes since 
its cromophore is adsorbed on the membrane interface. Therefore a possible 
explanation for this result is that the external location of this probe would not allow the 
correct distinction between partitioned-drug and free-drug. Moreover, since E.coli 
natural lipids form liposomes with a global external negative charge it is possible that 
an electrostatic interaction between the lipid polar heads and the drug was affecting the 
probe’s fluorescence and therefore interfering in the results. 
 
 
Fig. 28 Fit of the plot of 1/Kq
app
=f(αm), using eq.12). 
 
1.3.2.2 Partition Obtained with 12-AS 
As mentioned above the second n-AS probe used to calculate Kp of spx in E.coli 
liposomes was 12-AS. Unlike 2-AS, this probe is localized internally in the lipid bilayer. 
Therefore the fluorescence of this probe should only change when there is drug 
molecules partitioned in the lipid bilayer. For this reason, it is expected that unlike 2-
AS, 12-AS allows the determination of the Kp of the drug.  
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The emission spectra of the probe in the lipid (500µmol.dm-3) with increasing amounts 
of drug are presented on fig.29.  
 
 
Fig. 29 Fluorescence spectra of 12-AS/E.coli total lipid extract liposomes (500 µmol.dm
-3
)  in HEPES buffer (pH 7,4) in 
absence and presence of increasing amounts of spx (10.0, 20.0, 30.0, 40.0, 50.0, 60.0, 70.0, 80.0 µmol.dm
-3
). 
 
Correction for the inner filter effect was applied as described above, using eq. 15 and 
16. The Stern-Volmer plots obtained as described above for the 2-AS probe are 
depicted in fig.30 for the different lipid concentration used (100, 250, 300, 400 and 500 
µmol.dm-3). The kq
app values calculated from the Stern-Volmer plots for each lipid 
concentration, considering that    of 12-AS probe is 11.545 ns [90], are shown in table 
5.  
 
 
Fig. 30 Stern-Volmer plot of I0/I=f(|spx|), for the different lipid concentration used (100, 250, 300, 400, 500 µmol.dm
-3
). 
Fit of eq. 11). 
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Table 5 List of the different lipid concentration and correspondent αm used and the Kq
app
 obtained from the Stern-Volmer 
plot of I0/I=f(|spx|). 
|Lipid| / µmol.dm-3 αm / (x10
-3) mg.ml-1 kq
app / (x1012) mol-1.dm3.s-1 
100 0.096 1.24 
250 0.24 0.911 
300 0.29 0.903 
400 0.38 0.845 
500 0.48 0.757 
 
As expected, using this probe, the quenching obtained upon addition of the same 
amount of drug increased with the decrease of lipid concentration. Therefore, the plot 
of 1/kq
app= f(αm) enabled the calculation of Kp and kq for spx in E.coli total lipid extract 
LUV’s (fig. 17). The values of Kp and kq obtained are shown in table 6.  
 
Fig. 31  Fit of the plot of 1/Kq
app
=f(αm), using eq.12). 
 
Table 6 Kq and partition coefficient of sparfloxacin in E.coli total liposomes calculated using fit of eq. 12). 
 
 
 
 
The kq, bimolecular quenching constant, reflects the efficiency of quenching or the 
accessibility of the quencher to the fluorophore [43]. The value of kq obtained in this 
study is similar to those observed for other membrane lipid systems: EPC - 3,86-5,26 x 
108 dm3.mol-1.s-1 [89]; DPPC- 0.21-1.9 x 109 dm3.mol-1.s-1[99]. Moreover, the kq value 
obtained for this system is significantly smaller than the ones generally obtained for 
isotropic solutions (~ 1 x 1010 dm3.mol-1.s-1). This is explained by the fact that in 
heterogeneous systems there is less movement of the molecules and generally 
  
Log(Kp) 3.25 ±0.09 
kq  / (x10
8) dm3.mol-1.s-1 7.8 ±1.0 
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diffusion in these systems is bidimensional instead of tridimensional [43]. Moreover, 
diffusion of molecules is also hampered by the higher viscosity of these systems.  
The log(Kp) value obtained is similar, within experimental error, to the results obtained 
by NMR spectroscopy and UV-vis spectroscopy. 
 
1.3.3 Partition of Sparfloxacin with PE:PG Liposomes using 
Fluorescent Probes Incorporated in the Lipid Bilayer  
As described previously, the E.coli liposomes we had been using in the previous 
studies are a natural membrane lipid extract. Therefore these lipids have special 
characteristics that distinguish it from other synthetic lipids. First of all, E.coli total lipid 
extract is a complex lipid mixture, with only ~82,4% of its composition known and it also 
has four lipid transition temperatures [50]. As a natural membrane lipid extract, with 
high heterogeneity and complex composition, this is a complex system to study. 
Moreover, PE/PG binary systems are widely used as model systems for the E. coli 
membrane [95, 100, 101]. Therefore we determined the partition of spx in PE:PG 
(75:25) liposomes in order to confirm the results obtained previously for E. coli natural 
lipid extract. Kp was determine using 12-AS probe, inserted in the lipid bilayer, as 
described above. Fig.32 shows the emission spectra of the lipid without drug and with 
increasing drug concentration for the highest lipid concentration used (500µmol.dm-3).  
 
 
Fig. 32 Fluorescence spectra of 12-AS/PEPG(75:25) liposomes (500 µmol.dm
-3
)  in HEPES buffer (pH 7,4) in absence 
and presence of increasing amounts of spx (10.0, 20.0, 30.0, 40.0, 50.0, 60.0, 70.0, 80.0 µmol.dm
-3
). 
 
The Stern-Volmer plots, calculated for the different lipid concentration used (100, 250, 
400 and 500 µmol.dm-3), after inner filter effect correction at probe’s excitation 
 
|spx| 
 80 µmol.dm-3   
0 µmol.dm-3 
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wavelenght (eq. 15 and 16), are shown in fig.33. The kq
app values calculated from the 
Stern-Volmer plots for each lipid concentration are shown in table 7.  
 
Fig. 33  Stern-Volmer plot of I0/I=f(|spx|), for the different lipid concentration used (100, 250, 400, 500 µmol.dm
-3
). Fit of 
eq. 11) 
 
Table 7 List of the different lipid concentration and correspondent αm used and the Kq
app
 obtained from the Stern-Volmer 
plot of I0/I=f(|spx|). 
 
|Lipid| / µmol.dm-3 αm / (x10
-3) mg.ml-1 kq
app / (x1012) mol-1.dm3.s-1 
100 0.073 1.25 
250 0.18 1.08 
400 0.29 0.902 
500 0.37 0.841 
 
 
The plot of 1/kq
app= f(αm) was then traced (fig.34) and allowed the determination Kp and 
kq of spx in PE/PG (75:25), values that are listed in table 8.  
 
 
 
Fig. 34 Fit of the plot of 1/Kq
app
=f(αm), using eq.12).  
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Table 8 Kq and partition coefficient of sparfloxacin in PE:PG(75:25) liposomes calculated using fit of eq. 12). 
  
Log(Kp) 3.30 ±0.03 
kq  / (x10
8) dm3.mol-1.s-1 7.3 ±0.4 
 
The kq value obtained is, as expected, similar to the one obtained for E.coli lipid extract. 
This result is explained by the fact that both systems have similar composition and thus 
viscosity. Finally, the log(Kp) value obtained is also similar, within experimental error, to 
the one obtained for E.coli natural lipid extract. This result is important since it proofs 
that Kp value obtained from this technique with the more complex system is valid.  
 
1.4 Partition Calculated by Multiple Techniques- Conclusion 
Analysing the log(Kp) values obtained by the different methods used and comparing 
them we can conclude that they are similar within experimental error (table 9). 
Therefore, with these results we can show that the use of these techniques is a valid 
and useful approach to determine the partition coefficient of a non-fluorescent drug in a 
heterogeneous membrane system.  Moreover, The Kp value obtained for this antibiotic 
is significantly smaller than the ones obtained for other fluoroquinolones, as for 
example moxifloxacin [28].  
 
Table 9 Comparison of the Kp values of spx in E.coli natural extract liposomes, calculated using different spectroscopic 
techniques. 
  Log(Kp) 
UV-vis spectroscopy 
Non-Linear curve fit 3.4 ±0.4 
Lineweaver-Burk fit 3.9 ±0.1 
NMR spectroscopy 
Non-Linear curve fit 3.4 ±0.1 
Lineweaver-Burk fit 3.6 ±0.1 
Fluorescence spectroscopy 3.24 ±0.09 
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2. Partition Coefficient of Sparfloxacin 
Copper Complex 
As stated before one of the goals of the present study was to improve the knowledge 
about the interaction of spx with bacterial lipid membrane. This is an important issue to 
counteract bacterial resistance to fluoroquinolones since the decrease of permeability 
of the cell by mutation of the porins required for drug transport across the membrane is 
one of the main mechanisms of resistance of bacteria [23]. Therefore, the study and 
production of new antimicrobial agents, with improved ability to cross the lipid bilayer 
has been having a great interest to try to counteract bacterial resistance. For this 
purpose, the interest in metal complexes of antibiotics has been increasing since these 
metalloantibiotics show potentiated effect on antibacterial activity [24, 102-104]. For 
example Co(II) and Cu(II) complexes with spx exhibited a significant enhancement 
against several pathogenic bacteria than spx [30, 105]. Moreover, studies on drug-lipid 
interactions showed that fluoroquinolones and their metalloantibiotics interact 
differently with the model systems of bacterial membranes [27, 28]  
Thereby, we proceeded our study with the determination of the partition coefficient of 
the ternary complex of spx with Cu(II) and phenanthroline -[Cu(II)/spx/phen] (1:1:1)- in 
E.coli total lipid extract. As spx, [Cu(II)/spx/phen] is a non-fluorescent molecule. 
Therefore, among the techniques used before, we chose the fluorescence 
spectroscopy, using the 12-AS probe, to determine the Kp of this compound. 
   
 
2.1 Determination of Partition Coefficient by Fluorescence 
Spectroscopy 
2.1.1 Lambert-Beer Law of [Cu(II)/spx/phen]  
As described before, the determination of the absorption of a sample at the probe’s 
excitation and emission wavelength is essential to the fluorescent studies, since it 
allows the determination of the suitable range of complex concentration to be used in 
order to minimize the inner filter effect. The absorbance spectra of [Cu(II)/spx/phen] are 
presented in fig.35. Using the absorbance of the complex at 12-AS excitation 
wavelength (363 nm) vs [Cu(II)/spx/phen] we found that the suitable |[Cu(II)/spx/phen]| 
concentration to be used in fluorescence studies was  [0-50 μmol.dm-3] (fig.36). 
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Moreover, as for spx, complex absorption at probe’s emission wavelength (455-460 
nm) was non-relevant and it was not necessary to correct for inner filter effect at this 
wavelength. 
 
Fig. 35 Absorption spectra of [Cu(II)/spx/phen] solutions in HEPES buffer (pH 7.4) with increasing complex 
concentration (3.874, 7.747, 11.621, 15.494, 19.368, 24.210, 29.052, 38.736 µmol.dm
-3
) at 37.0°C. 
 
 
 
Fig. 36  Lambert-Beer law for [Cu(II)/spx/phen] solutions (3.874, 7.747, 11.621, 15.494, 19.368, 24.210, 29.052 
µmol.dm
-3
) at 12-AS probe excitation wavelength (363 nm). 
 
 
2.1.2 Partition of [Cu(II)/spx/Phen] with E.coli Total Lipid Extract 
using 12-AS Probe Incorporated in the Lipid Bilayer. 
Based on the results obtained previously for spx, we chose to use the 12-AS probe 
incorporated in the lipid bilayer in order to calculate the partition of the [Cu(II)/spx/phen] 
complex by fluorescence spectroscopy. The quenching data was analysed as 
previously described (1.3.2.). Fig.37 shows the fluorescence spectra of the lipid without 
drug and with increasing drug concentration for the highest lipid concentration used 
(600µmol.dm-3). 
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Fig. 37 Fluorescence spectra of 12-AS/E.coli total lipid extract liposomes (600 µmol.dm
-3
)  in HEPES buffer (pH 7,4) in 
absence and presence of increasing amounts of [Cu(II)/spx/phen] (10.0, 20.0, 30.0, 40.0, 50.0, 60.0, 70.0, 80.0 
µmol.dm
-3
). 
 
The Stern-Volmer plots were calculated as explained before for spx and are shown in 
fig.38. The kq
app values calculated from the Stern-Volmer plots for each lipid 
concentration used are shown in table 10.  
 
 
Fig. 38 Stern-Volmer plot of I0/I=f(|Cu(II)/spx/phen|), for the different lipid concentration used (100, 200, 300, 400, 500, 
600 µmol.dm
-3
). Fit of eq. 11) 
 
Table 10 List of the different lipid concentration and correspondent αm used and the Kq
app
 obtained from the Stern-
Volmer plot of I0/I=f(|[Cu(II)/spx/phen|). 
 
|Lipid| / µmol.dm-3 αm / (x10
-3) mg.ml-1 kq
app / (x1012) mol-1.dm3.s-1 
100 0.096 4.899 
200 0.193 4.625 
300 0.289 3.763 
400 0.385 3.496 
500 0.482 3.431 
600 0.578 3.214 
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The plot of 1/kq
app= f(αm) is depicted in fig. 39. The values of Kp and kq obtained from 
the plot of 1/kq
app= f(αm), as described for Lakowickz [43] , are shown in table 11.  
 
 
 
Fig. 39 Fit of the plot of 1/Kq
app
=f(αm), using eq.12). 
 
 
 
Table 11 Kq and partition coefficient of sparfloxacin copper complex in E.coli total liposomes calculated using fit of eq. 
12). 
  
Log(Kp) 3.11 ±0.08 
kq  / (x10
9) dm3.mol-1.s-1 4.2 ±0.5 
  
 
The Kp obtained for the complex is slightly smaller than the one obtained for the free-
drug. This is an unexpected result, since previous studies showed higher partition in 
E.coli total extract liposomes for the metal complex of fluoroquinolones, when 
compared to the free drug [27, 28]. However, these studies suggest that the higher Kp 
values obtained for the metal complexes of the fluoroquinolones results from the 
electrostatic interaction between the positively charged metal complex and the 
negatively charged lipid headgroups. Therefore, since we were using a fluorescent 
probe that is localized internally in the lipid bilayer, our result should not “reflect” this 
electrostatic interaction. In fact, our results suggests that, at least for the spx copper 
complex, the amount of drug that is partitioning inside the lipid bilayer is similar to the 
one for spx free drug. 
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3. Association Constants 
As explained before, bacterial resistance to fluoroquinolones can be related to 
numerous mechanisms, one of them involving the decrease of the internalization of the 
antibiotic in the bacterial cell. Therefore, one of the main known mechanisms of 
resistance of Gram – bacteria to fluoroquinolones is the mutation in the expression of 
the channel protein OmpF [106] . Some studies showed the importance of this protein 
in the transport of drugs across the bacterial outer membrane. However, although it 
has been showed that strains of E.coli mutated for OmpF are resistant to some 
fluoroquinolones, the mechanism of permeation of these drugs is still unrevealed. In 
fact, it is possible that, at least some fluoroquinolones are capable to use both the 
channel porin or the lipid/protein interface in order to cross the Gram – bacteria outer 
membrane [76, 106]. The study of the interaction between fluoroquinolones and the 
bacterial porin OmpF can bring new information, helping in the development of new 
fluoroquinolones, with less susceptibility to bacterial resistance. Therefore, this study is 
extremely important to counteract the problem of the bacterial resistance. 
In this work, we studied the interaction of spx, either as a free drug or complexed with 
copper and phenanthroline, with proteoliposomes of OmpF in E.coli total lipid extract.  
In an attempt to determine the association constant (Ka) of these drugs we chose to 
use two different techniques: fluorescence spectroscopy and Surface Plasmon 
Resonance (SPR). 
 
 
3.1 Determination of Sparfloxacin Association Constant by 
Fluorescence Spectroscopy. 
3.1.1 Lambert-Beer Law of Sparfloxacin. 
Once more, the determination of the absorption of the sample at the λmáx of excitation 
and emission is essential to find the suitable range of spx concentration to be used 
and, also, to find if inner filter correction is necessary. Fig.40 shows the superimposed 
spectra of excitation and emission of OmpF/E.coli total lipid extract proteoliposomes 
and absorption of spx. 
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Fig. 40 Overlap of spx absorption spectrum (15.291 µmol.dm
-3
) and E.coli total lipid extract/OmpF proteoliposomes 
fluorescence spectra (1 mmol.dm
-3
). A- superimposed spectra of spx absorption and proteoliposomes fluorescence 
excitation. B – superimposed spectra of spx absorption and proteoliposomes fluorescence emission. 
 
As can be found from fig.40, for this experiment it was necessary to correct the inner 
filter effects both for the excitation and emission wavelength. Thus, the plot of spx 
absorbance vs drug concentration was plotted for both the λmáx of excitation and 
emission (290 nm and 320 nm) and is represented on fig. 41. Analysing the plots 
represented in fig. 41, we found that the best range of spx concentration to be used in 
order to have a valid inner filter effect correction is [0-15 μmol.dm-3]. 
 
 
Fig. 41 Lambert-Beer law of spx solutions (3.058, 7.645, 11.468, 15.291, 19.113, 22.936, 26.758, 30.581 and 38.226 
µmol.dm
-3
) in HEPES buffer (pH 7.4) at OmpF-Trp maximum excitation and emission wavelengths ( 290 nm and 
320nm). 
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3.1.2 Association Constant of Spx with E.coli Total Lipid 
Extract/OmpF Proteoliposomes by Fluorescence 
Spectroscopy. 
The determination of the Ka between a drug and a protein by fluorescence 
spectroscopy is, usually, based on the fact that proteins have intrinsic fluorescence, 
due to the presence of tyrosine and tryptophan residues. Commonly, the interaction 
between a protein and a drug is studied by its interaction with the tryptophan residues 
of the protein [43]. Protein OmpF is a trimmer when inserted in a lipid membrane and it 
has two tryptophan residues in each monomer, localized in the lipid-protein interface 
(Trp214.Trp61) [45, 106]. Therefore, in the present study, the determination of Ka 
between spx and OmpF/E.coli total lipid extract proteoliposomes was based on the 
alteration of the tryptophan fluorescence by addition of increasing amounts of drug. 
The λ of excitation used was 290 nm, in order to guarantee the excitation of the 
tryptophan residues, uniquely [45]. The fact that the λmáx of emission occurs at low 
wavelength indicates that the tryptophan residues are localized in hydrophobic regions 
of the protein[106]. Fig.42 shows the emission spectra of the OmpF/E.coli total lipid 
extract proteoliposomes upon addition of increasing amounts of spx. As exposed, the 
addition of spx caused a decrease in the fluorescence intensity of the proteoliposomes 
spectra. 
 
 
Fig. 42 Fluorescence spectra of E.coli total lipid extract/OmpF proteoliposomes (1 mmol.dm
-3
)  in HEPES buffer (pH 
7,4) in absence and presence of increasing amounts of spx (1.39, 2.97, 4.51, 6.01, 7.46, 8.88, 10.56, 12.19, 13.76, 
15.29 µmol.dm
-3
). 
 
Ka was determined from the Stern-Volmer equation, using the data in the plot of 
Io/I=f(|spx|), represented in fig. 43. This plot was obtained using the data from the 
fluorescence emission of the proteoliposomes without and with increasing amounts of 
 
|spx| 
 15 µmol.dm-3   
0 µmol.dm-3 
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spx (0-15 µmol.dm-3), at tryptophan’s emission λmáx (320 nm). Correction for the inner 
filter effect was applied as described above, using eq. 15 and 16.  
The value of log(ka) obtained for spx with OmpF/E.coli total lipid extract 
proteoliposomes is shown in table 12. 
 
Fig. 43 Stern- Volmer plot of I0/I=f(|spx|). Fit of eq 17). 
 
Table 12 Association constant of sparfloxacin with E.coli total lipid extract/OmpF proteoliposomes calculated using fit of 
eq. 17). 
  
Log(Ka) / mol
-1.dm3 4.04 ± 0.01 
 
 
3.2 Determination of [Cu(II)/spx/phen] Association Constant by 
Fluorescence Spectroscopy. 
 
3.2.1 Lambert-Beer Law of [Cu(II)/spx/phen] 
As for spx free drug, the absorption of [Cu(II)/spx/phen] at the λmáx of excitation and 
emission was determined in order to find the suitable range of drug concentration to be 
used in the fluorescent studies and to find if inner filter effect correction was necessary. 
Fig.44 shows the superimposed spectra of excitation and emission of OmpF/E.coli total 
lipid extract proteoliposomes and absorption of [Cu(II)/spx/phen]. 
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Fig. 44 Overlap of [Cu(II)/spx/phen] absorption spectrum (11.621 µmol.dm
-3
) and E.coli total lipid extract/OmpF 
proteoliposomes fluorescence spectra (1 mmol.dm
-3
). A- superimposed spectra of [Cu(II)/spx/phen] absorption and 
proteoliposomes fluorescence excitation. B – superimposed spectra of [Cu(II)/spx/phen] absorption and 
proteoliposomes fluorescence emission. 
 
Once again, the spx complex absorbs both at excitation and emission λmáx of 
tryptophan residues, then it was necessary to correct the results for both the 
wavelengths. Therefore, the plot of [Cu(II)/spx/phen] absorbance vs concentration was 
traced for both the λmáx of excitation and emission (290 nm and 320 nm). Analysing the 
plots represented in fig. 45, we found that the best range of complex concentration to 
be used in order to have a good inner filter effect correction is [0-9 μmol.dm-3]. 
 
 
Fig. 45   Lambert-Beer law of [Cu(II)/spx/phen] solutions (3.874, 7.747, 11.621, 15.494, 19.368, 24.210, 29.052 
µmol.dm
-3
) in HEPES buffer (pH 7.4) at OmpF-trp maximum excitation and emission wavelengths ( 290 nm and 320nm). 
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3.2.2 Association Constant of [Cu(II)/spx/phen] with E.coli total lipid 
extract/OmpF proteoliposomes by fluorescence spectroscopy. 
As described for spx free drug, the spectrofluorimetric determination of Ka between a 
drug and a protein is based on the alteration of the tryptophan fluorescence by addition 
of increasing amounts of drug. Once more, the λmáx of excitation used was 290 nm, in 
order to guarantee the excitation of the tryptophan residues, uniquely [45]. The 
emission spectra of the OmpF/E.coli total lipid extract proteoliposomes obtained 
without and with addition of increasing amounts of [Cu(II)/spx/phen] is presented on 
fig.46.  
 
Fig. 46 Fluorescence spectra of E.coli total lipid extract/OmpF proteoliposomes (1 mmol.dm
-3
)  in HEPES buffer (pH 
7,4) in absence and presence of increasing amounts of [Cu(II)/spx/phen] (0.83, 1.75, 2.63, 3.69, 4.70, 5.67, 6.59, 7.47, 
8.32, 9.13 µmol.dm
-3
). 
 
The plot of Io/I=f(|[Cu/spx/phen]|), after application of inner filter effect correction 
(eq.15), was traced (fig.47) in order to determine the Ka, as explained before. This plot 
was traced using the fluorescence emission of the proteoliposomes without and with 
increasing amounts of [Cu(II)/spx/phen] (0-9 µmol.dm-3), at tryptophan’s emission λmáx 
(320 nm).  
As we can see from fig.47, the plot of Io/I=f(|[Cu/spx/phen]|) for this drug is  not a 
straight line and thus doesn’t fit in the Stern-Volmer equation. Therefore, the calculation 
of Ka of the complex [Cu(II)/spx/phen] using fluorescence spectroscopy was not 
possible. 
 
 
|[Cu(II)/spx/phen]| 
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Fig. 47 Plot of I0/I=f(|Cu(II)/spx/phen|).  
 
Since the overlapped spectra of the spx copper-complex with the proteoliposomes 
shows superimposition at emission wavelength of the OmpF we tried to find out if 
resonance energy transfer (RET) was the main process occurring. Briefly, RET 
consists in an energy transfer between a donor (the fluorophore- OmpF) and an 
acceptor (the quencher – [Cu(II)/spx/phen]), which is established by dipole-dipole 
interactions in the excited state. The efficiency of energy transfer depends on both the 
distance between the donor and the acceptor and the extension of their spectral 
superimposition. [43, 55] 
The theoretical efficiency of energy transfer is calculated from the degree of 
fluorescence extinction of the donor induced by the acceptor: 
 
    
    
   
 (  
∫      ( )  
 
 
∫    
 
 
 ( )  
)  
Where      and     are the decay of fluorescence intensity of the donor in the 
presence and absence of the acceptor, respectively. 
In contrast, the experimental efficiency of energy transfer is calculated from the relative 
fluorescence intensity of the donor in the absence (  ) and presence (   ) of the 
acceptor: 
    
   
  
 
 
The comparison between the theoretical and the experimental energy transfer between 
[Cu(II)/spx/phen] and OmpF resulted in a disparity between the two plots, suggesting 
that another interaction rather than RET is also present (fig.48).  
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Fig. 48 Plot of efficiency of energy transfer vs the quantity of acceptor. Squares – theoretical energy transfer; diamond – 
experimental energy transfer. 
 
Therefore, the possible explanation for our result is that, due to the high absorption of 
[Cu(II)/spx/phen] at both excitation and emission wavelength of OmpF, the high inner 
filter effect obstructs the correct determination of the interaction between 
[Cu(II)/spx/phen] and OmpF by fluorescence spectroscopy. Therefore, the use of time-
resolved fluorescence spectroscopy would be an important approach, since this 
technique is not dependent on quencher concentration, neither affected by inner filter 
effect. 
 
 
3.3 Determination of Association Constants by Surface 
Plasmon Resonance. 
Since the determination of the association constant of the copper complex of spx with 
OmpF by spectrofluorimetry was not possible, SPR was used has an additional 
technique in the study of the [Cu(II)/spx/phen]/OmpF interaction. 
As described before, SPR is a widely used technique in the study of protein-ligand 
interactions and the use of the L1 chip allows the study of the interaction between 
membrane proteins and ligands.[86] 
Therefore, in this study Ka of [Cu(II)/spx/phen] with OmpF protein was determined by 
SPR. Additionally, spermine, an OmpF channel blocker, was used as a positive control 
and the interaction between spx free drug and OmpF was also studied [107]. 
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3.3.1 Proteoliposome Deposition 
An important first step in an SPR experiment is to define the best experimental 
conditions in order to guarantee an efficient lipid deposition. Fig.49 shows E.coli lipid 
extract/OmpF proteoliposomes deposition at two different concentrations (1 and 2 
mmol.dm-3), two different contact time (2500 and 2700 s), and with or without injecting 
NaOH (10 mmol.dm-3), after liposome deposition, in order to remove loosely bound 
lipids and stabilize baseline. 
 
Fig. 49 SPR sensorgram of the proteoliposome deposition with different experimental conditions: 1mmol.dm
-3
: light 
blue- contact time 2500s; dark blue- contact time 2700s; orange – contact time 2500s and enhancement with NaOH 10 
mmol.dm
-3
; brown- contact time 2700s and enhancement with NaOH 10 mmol.dm
-3
 . 2mmol.dm
-3
: light green – contact 
time 2500 s; dark green- contact time 2700 s 
 
As can be seen from fig.49 the proteoliposome concentration of 2 mmol.dm-3 and 
contact time of 2700 s are the best experimental conditions to ensure the highest SPR 
signal and a complete coverage of the sensorchip (stabilization of the signal). The use 
of NaOH (10 mmol.dm-3), cause a small decrease in the signal and therefore its use 
should be important to remove loosely bound lipids and stabilize signal. 
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3.3.2 Spermine as a Positive Control 
The use of a positive control is an essential step in a SPR experiment since it allows 
the validation of the experimental approach used.  
Spermine is a known OmpF-channel blocker and thus it was used in this study as a 
positive control [107]. It is important to be sure that the signal detected is a result of the 
specific interaction between the analyte and OmpF protein. In order to subtract 
possible spermine interaction with the lipids, two parallel experiments were carried out 
in the different flow channels: in channel 1 E.coli natural lipid extract liposomes were 
used whether in channel 2 E.coli lipid extract/OmpF proteoliposomes were used. The 
final signal is a result of the subtraction of the results obtained is both channels 
(channel 2-1).  
As can be seen from the SPR sensorgram (channel 2-1) represented in fig.50, the 
interaction between spermine and OmpF is too fast to fit kinetics analysis. However, it 
reaches steady state and, thus, it is possible to determine the association constant by 
steady-state binding analysis. 
 
Fig. 50     Plot of SPR signal with time (t), for  different spermine concentrations. From t=0s to t~200s is the association 
time, in which spermine is injected in the flow channel; from t~200s on is the dissociation time.  
 
As can be seen from fig. 51, the plot of SPR signal in the steady-state (178 s) vs 
spermine concentration has a common affinity curve pattern. Therefore, the non-linear 
fit of the plot of SPR signal= f(|spermine|), using eq.18), allows the determination of Ka 
and Rmáx (fig.51, table 13) 
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Fig. 51 Plot of SPR signal=f(|spermine|). Non linear fit of the plot was performed using eq.18).  
 
 
Table 13 Association constant of Spermine in E.coli total lipid extract/OmpF proteoliposomes and Rmáx, calculated using 
fit of eq. 18). 
  
Log(Ka)/ mol
-1.dm3 4.4 ± 0.2 
Rmáx / UR 67 ± 5 
 
 
3.3.3 Determination of Association Constant between 
[Cu(II)/spx/phen] and OmpF 
The interaction between [Cu(II)/spx/phen] and OmpF reconstituted in E.coli natural 
extract liposomes was studied by SPR. Since the copper complex of OmpF strongly 
interacts with the negatively charge polar heads of the E.coli membrane phospholipids, 
it was again essential to subtract the interaction of [Cu(II)/spx/phen] with the liposomes 
from its real interaction with OmpF protein. As explained for spermine, the final SPR 
signal is a result of the subtraction of the results obtained in the two channels (channel 
2-1). 
Fig.52 shows the SPR sensorgram (channel 2-1) for the different [Cu(II)/spx/phen] 
concentration used. As for spermine, [Cu(II)/spx/phen] interaction with OmpF is too fast 
to correctly allow a kinetic analysis, thus a steady-state binding analysis was carried 
out.  
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Fig. 52 Plot of SPR signal with time (t), for  different [Cu(II)/spx/phen] concentrations. From t=0s to t~200s is the 
association time, in which drug is injected in the flow channel; from t~200s on is the dissociation time.  
 
The fit of SPR signal at the steady-state vs |[Cu(II)/spx/phen]| (fig.53) allows the 
determination of Kd that subsequently allows the calculation of Ka. 
Rmáx, and Ka values obtained from the non-linear fit of the plot SPR signal vs 
concentration of [Cu(II)/spx/phen] are listed in table 14. 
 
 
Fig. 53 Plot of SPR signal=f([Cu(II)/spx/phen]|). Non linear fit of the plot was performed using eq.18). 
 
Table 14 Association constant of [Cu(II)/spx/phen] in E.coli total lipid extract/OmpF proteoliposomes and Rmáx, 
calculated using fit of eq. 18). 
  
Log(Ka)/ mol
-1.dm3 3.3 ± 0.2 
Rmáx / UR 250 ± 45 
 
The value of Ka obtained for [Cu(II)/spx/phen] is, as expected, lower than the one 
obtained for spermine, since spermine is a known OmpF channel blocker and the 
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copper-complex of spx is expected not to have a high affinity to OmpF channel, since it 
is supposed that it uses a different route to pass through bacterial membrane. 
Moreover, comparing the value obtained for [Cu(II)/spx/phen]/OmpF association by 
SPR with the one obtained for spx/OmpF association by spectrofluorimetry, the spx 
association with the protein channel is significantly higher.  
Another SPR result that supports the idea that spx copper-complexed drug uses a 
different route to go through bacteria membrane is its strong interaction with the lipid 
portion of the E.coli/OmpF proteoliposomes. This interaction is proved by the fact that 
SPR signal of the interaction between [Cu(II)/spx/phen] and proteoliposomes using as 
a reference the nude L1 sensorchip in channel 1 instead of E.coli liposomes attached 
to the sensorchip, is significantly higher for lower [Cu(II)/spx/phen] concentration. Fig. 
54 shows the plot of SPR signal (channel 2-1) with time using proteoliposomes in 
channel 2 and the nude L1 sensorchip in channel 1.  
 
 
Fig. 54 Plot of SPR signal with time (t) (channel 2-1), for different [Cu(II)/spx/phen] concentrations, using L1 nude chip 
in channel 1.  From t=0s to t~200s is the association time, in which drug is injected in the flow channel; from t~200s on 
is the dissociation time. 
 
3.3.4 Determination of Association Constant between Spx and 
OmpF 
The interaction of spx free drug with OmpF protein reconstituted in Gram – model 
membranes was also tested by SPR. A similar experiment with the one performed for 
spx-copper complex was carried on. However, for spx free drug, the SPR signal upon 
interaction with OmpF is too small and it is affected by a high error (fig.55). Thereby, 
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determination of the association constant between spx and OmpF by this technique 
was not possible. A possible explanation for this result is the very small molecular 
weight of spx when compared to the proteoliposomes that did not allow a correct 
detection of spx interaction with the OmpF protein by this technique. 
 
Fig. 55  Plot of SPR signal with time (t), for the different spx concentrations used (8, 40, 70, 100, 200 µmol.dm
-3
). From 
t=0s to t~200s is the association time, in which drug is injected in the flow channel; from t~200s on is the dissociation 
time. 
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IV. CONCLUSION AND FUTURE 
PERSPECTIVES 
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The abusive use of quinolones has been resulting in the increase of bacterial 
resistance to these drugs, which constitutes an emerging and serious public health 
issue [18]. Since quinolones target-site is located inside the bacterial cell, one of the 
main mechanisms of bacterial resistance to these drugs is the decrease of drug 
internal concentration [1, 19]. Therefore, the improvement of the knowledge about 
quinolones internalization in bacterial cell is an essential step to find new insights in the 
combat of bacteria resistance to these drugs. 
In this work we studied sparfloxacin, a third generation fluoroquinolone, interaction with 
Gram – bacterial membrane. Sparfloxacin, in its free form, is a hydrophilic molecule 
and therefore it is expected that it could not pass extensively through bacterial 
membrane without the help of transport proteins [15, 108]. The quantitative analysis of 
partition of sparfloxacin in E.coli natural lipid extract liposomes resulted in a log(Kp) 
value of 3.2 to 3.9, depending on the technique used. This is a slightly smaller partition 
value when compared to other fluoroquinolones: enrofloxacin (log(Kp) =3.94) [27], 
moxifloxacin (log(Kp)=4.15 [28]) or ciprofloxacin (log(Kp) =4.87 [unpublished results]). 
This smaller Kp value can be explained by the fact that pKa2 of sparfloxacin is the 
smallest among fluoroquinolones (pKa2 =7.42). Thus, unlike other fluoroquinolones, at 
physiological pH (pH=7.4) a substantial portion of sparfloxacin is in a negative form 
instead of zwitterionic form. This small partition value of sparfloxacin suggests that it 
needs the help of a transport protein to cross bacterial membrane, characteristic that is, 
generally, shared with other fluoroquinolones. 
It is known that the main protein responsible for fluoroquinolone transport through 
Gram – bacterial membrane is the general porin OmpF, thus a high interaction 
between sparfloxacin and OmpF could be expected. The quantitative study of the 
association between sparfloxacin an OmpF porin resulted in a log(Ka) value of 4.04 
mol-1.dm3. This value is again slightly smaller when compared to other fluoroquinolones 
(ciprofloxacin: 3.85-4.55 mol-1.dm3; grepafloxacin: 4.02-4.57 mol-1.dm3 ; moxifloxacin: 
4.27-4.65 mol-1.dm3) [76]. Therefore, this result suggests that sparfloxacin transport 
through bacterial membrane is not, at least totally, dependent on OmpF porin.  
Moreover, microbiological results showed that, unlike what happens for other 
fluoroquinolones, for sparfloxacin the minimum inhibitory concentration (MIC) obtained 
for E.coli strains with single deletion of the porin OmpF is similar to the one obtained for 
the wild-type strain. Furthermore, a remarkable result is the fact that OmpC deletion in 
E.coli apparently increases the bacteria susceptibility to spx, since the MIC obtained is 
smaller than the one obtained for the parental strain. [14] To explain this result Feio, M. 
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et al suggested that a mechanism of differential regulation could be occurring: the 
absence of OmpC leads to a up-regulation and greater availability of other porin 
channels (i.e. OmpF) and, thus, spx transport is favoured [14]. This result is in 
agreement with the smaller association constant from spx and OmpF, when compared 
to other fluoroquinolones. Moreover, the combination of Ka and microbiological results 
suggests that, besides the OmpF dependent transport, sparfloxacin can use an 
alternative pathway to enter bacterial cell, perhaps a different channel protein. 
Therefore, further studies on membrane protein’s dependence of sparfloxacin transport 
across bacterial membrane could be extremely important to understand its uptake 
mechanism. 
Previous studies showed that sparfloxacin complexation with copper(II) and 
phenanthroline resulted in compounds with similar or higher antibacterial activity when 
compared to the free-drug [14, 30, 31] and higher activity when compared to other 
[Cu(II)/quinolone] complexes [30]. Moreover, copper-quinolone complexes generally 
have higher partition in Gram – lipidic model membranes than the free drug, probably 
due to its positive charge that allows a higher interaction with the negatively charge 
polar heads of Gram – membrane phospholipids. The logarithm of partition coefficient 
of [Cu(II)/spx/phen] in E.coli natural lipid extract liposomes calculated in this study was 
3.11. Contrasting with what was expected, the partition value is similar to the one 
obtained for the free drug. Moreover the partition coefficient obtained for 
[Cu(II)/spx/phen] is much smaller than the ones obtained for other fluoroquinolone 
complexes ([Cu(II)/erx/phen]: log(Kp)=4.85 [29]; [Cu(II)/mox/phen]: log(Kp)=4.75 [28]). 
However, these different partition values can be explained by the fact that our partition 
coefficient was determined using a fluorescent probe that is located internally in the 
lipid bilayer while, in the other studies, partition coefficient was determined by direct 
quenching of fluoroquinolone fluorescence by addition of liposomes. Moreover, the 
SPR experiment suggested a high interaction between E.coli natural lipid extract 
liposomes and [Cu(II)/spx/phen]. Consequently, this combination of results suggest that 
in fact copper-sparfloxacin complexes should use a different route to enter bacterial 
cell, possibly promoted by the high lipid/antibiotic superficial interaction but they cannot 
pass through the membrane lipid bilayer. Further studies on [Cu(II)/spx/phen] 
localization using other  -AS, located more externally in lipid bilayer, should be 
important to understand the complex internalization in bacterial cells. 
Previous studies also showed that copper-quinolone complexes transport through 
Gram – bacterial cell membrane is expected to be independent on OmpF porin, since 
OmpF mutant E.coli strains susceptibility to copper-quinolone complexes is similar to 
wild-type E.coli strains [14]. Our results confirm the independence on OmpF porin of 
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[Cu(II)/spx/phen] complex, since Ka value calculated for sparfloxacin-complex/OmpF is 
much smaller than the one obtained for sparfloxacin as a free drug and also for 
spermine, a specific OmpF blocker, used as a positive control: log(Ka) 
[Cu(II)/spx/phen]= 3.3 mol-1.dm3; log(Ka ) spx= 4.04 mol
-1.dm3; log(Ka ) spermine=4.4 
mol-1.dm3. 
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